☰

Robert J. Glynn - Publications

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Biostatistics Biology
Tree Info Similar researchers PubMed Report error

173/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fralick M, Kim SC, Schneeweiss S, Everett BM, Glynn RJ, Patorno E. Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study. Bmj (Clinical Research Ed.). 370: m2812. PMID 32843476 DOI: 10.1136/Bmj.M2812  0.333
2020 Ajala ON, Demler OV, Liu Y, Farukhi Z, Adelman SJ, Collins HL, Ridker PM, Rader DJ, Glynn RJ, Mora S. Anti-Inflammatory HDL Function, Incident Cardiovascular Events, and Mortality: A Secondary Analysis of the JUPITER Randomized Clinical Trial. Journal of the American Heart Association. e016507. PMID 32799709 DOI: 10.1161/Jaha.119.016507  0.346
2020 Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N. Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial. European Heart Journal. PMID 32221587 DOI: 10.1093/Eurheartj/Ehaa160  0.31
2020 Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, et al. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Annals of Internal Medicine. PMID 32066146 DOI: 10.7326/M19-3369  0.312
2020 Dave C, Kim SC, Goldfine A, Glynn R, Patorno E. 35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy Diabetes. 69. DOI: 10.2337/Db20-35-Or  0.342
2020 Dashti H, Liu Y, Glynn RJ, Ridker PM, Mora S, Demler O. Abstract P280: Revisiting CVD Risk Prediction Using Machine Learning Approaches: A Case Study Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P280  0.333
2020 Ajala ON, Demler O, Liu Y, Ridker P, Glynn RJ, Chasman D, Mora S. Abstract P260: Determinants of Statin Response: A Secondary Analysis of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Circulation. 141. DOI: 10.1161/Circ.141.Suppl_1.P260  0.312
2019 Akinkuolie AO, Lawler PR, Chu AY, Caulfield M, Mu J, Ding B, Nyberg F, Glynn RJ, Ridker PM, Hurt-Camejo E, Chasman DI, Mora S. Group IIA Secretory Phospholipase A and Incident Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA118311894. PMID 31070471 DOI: 10.1161/Atvbaha.118.311894  0.344
2019 PATORNO E, PAWAR A, SCHNEEWEISS S, GLYNN RJ, KIM DH, EVERETT BM, BESSETTE LG, KIM SC. 247-OR: Real-World Effectiveness of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in Patients With and Without Cardiovascular Disease Diabetes. 68: 247-OR. DOI: 10.2337/Db19-247-Or  0.33
2019 PATORNO E, KIM DH, PAWAR A, SCHNEEWEISS S, GLYNN RJ, MUNSHI M, BESSETTE LG, KIM SC. 156-OR: Risk-Benefit of SGLT2 Inhibitors (SGLT2i) vs. GLP-1 Receptor Agonists (GLP-1RA) in Routine Care of Older Adults Diabetes. 68: 156-OR. DOI: 10.2337/Db19-156-Or  0.331
2019 FRALICK M, KIM SC, SCHNEEWEISS S, EVERETT BM, GLYNN RJ, PATORNO E. 1539-P: Assessing the Risk of Amputation with Canagliflozin in Middle-Aged Adults and Adults over 65 Years of Age: An Observational Study Using Three Nationwide Databases Diabetes. 68: 1539-P. DOI: 10.2337/Db19-1539-P  0.31
2019 Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn R. COMPARATIVE PERFORMANCE OF FOUR CLAIMS-BASED FRAILTY MEASURES IN THE UNITED STATES MEDICARE DATA Innovation in Aging. 3: S684-S685. DOI: 10.1093/Geroni/Igz038.2526  0.318
2018 Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM. Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study. American Heart Journal. 206: 80-93. PMID 30342298 DOI: 10.1016/J.Ahj.2018.09.011  0.339
2018 Krumme AA, Glynn RJ, Schneeweiss S, Choudhry NK, Tong AY, Gagne JJ. Defining Exposure in Observational Studies Comparing Outcomes of Treatment Discontinuation. Circulation. Cardiovascular Quality and Outcomes. 11: e004684. PMID 29991646 DOI: 10.1161/Circoutcomes.118.004684  0.309
2018 Burkard T, Huegle T, Layton JB, Glynn RJ, Bloechliger M, Frey N, Jick SS, Meier CR, Spoendlin J. The risk of incident osteoarthritis of the hand in statin initiators:A sequential cohort study. Arthritis Care & Research. PMID 29885074 DOI: 10.1002/Acr.23616  0.301
2018 PATORNO E, EVERETT BM, SCHNEEWEISS S, GLYNN RJ, LIU J, KIM SC. Comparative Cardiovascular Effectiveness of SGLT2 Inhibitors vs. Liraglutide in Routine Care Diabetes. 67: 1492-P. DOI: 10.2337/Db18-1492-P  0.317
2018 Solomon D, Glynn RJ, MacFadyen JG, Libby P, Thuren T, Everett BM, Ridker PM. OP0014 Serum urate, gout, and cardiovascular disease in a randomised controlled trial of canakinumab: a cantos secondary analysis Annals of the Rheumatic Diseases. 77: 56-57. DOI: 10.1136/Annrheumdis-2018-Eular.1567  0.35
2018 Patorno E, Glynn RJ, Levin R, Huybrechts KF. BENZODIAZEPINES AND THE RISK OF ALL-CAUSE MORTALITY IN OLDER PATIENTS Innovation in Aging. 2: 852-853. DOI: 10.1093/Geroni/Igy023.3178  0.302
2018 Durazo EM, Cabeza de Baca T, Slopen N, Parikh NI, Buring JE, Glynn RJ, Albert MA. Parity, Job Strain, and Cardiovascular Risk in the Women’s Health Study Current Cardiovascular Risk Reports. 12. DOI: 10.1007/S12170-018-0571-Z  0.305
2017 Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, ... ... Glynn RJ, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. The New England Journal of Medicine. PMID 28845751 DOI: 10.1056/Nejmoa1707914  0.306
2017 Patorno E, Glynn RJ, Levin R, Lee MP, Huybrechts KF. Benzodiazepines and risk of all cause mortality in adults: cohort study. Bmj (Clinical Research Ed.). 358: j2941. PMID 28684397 DOI: 10.1136/Bmj.J2941  0.368
2017 Khera AV, Demler O, Adelman SJ, Collins HL, Glynn RJ, Ridker PM, Rader DJ, Mora S. Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events. An Analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin). Circulation. PMID 28450350 DOI: 10.1161/Circulationaha.116.025678  0.316
2017 Rautiainen S, Gaziano JM, Christen WG, Bubes V, Kotler G, Glynn RJ, Manson JE, Buring JE, Sesso HD. Effect of Baseline Nutritional Status on Long-term Multivitamin Use and Cardiovascular Disease Risk: A Secondary Analysis of the Physicians' Health Study II Randomized Clinical Trial. Jama Cardiology. PMID 28384735 DOI: 10.1001/Jamacardio.2017.0176  0.322
2017 Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJ, Koenig W, Lorenzatti A, Manga P, et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine. PMID 28304242 DOI: 10.1056/Nejmoa1701488  0.353
2016 Ridker PM, Amarenco P, Brunell R, Glynn RJ, Jukema JW, Kastelein JJ, Koenig W, Nissen S, Revkin J, Santos RD, Schwartz PF, Yunis C, Tardif JC. Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials. American Heart Journal. 178: 135-44. PMID 27502861 DOI: 10.1016/J.Ahj.2016.05.010  0.313
2016 Desai RJ, Glynn RJ, Wang S, Gagne JJ. Performance of Disease Risk Score Matching in Nested Case-Control Studies: A Simulation Study. American Journal of Epidemiology. 183: 949-57. PMID 27189330 DOI: 10.1093/Aje/Kwv269  0.319
2016 Rautiainen S, Rist PM, Glynn RJ, Buring JE, Gaziano JM, Sesso HD. Multivitamin Use and the Risk of Cardiovascular Disease in Men. The Journal of Nutrition. PMID 27121531 DOI: 10.3945/Jn.115.227884  0.314
2016 Kumamaru H, Schneeweiss S, Glynn RJ, Setoguchi S, Gagne JJ. Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical data. Emerging Themes in Epidemiology. 13: 5. PMID 27053942 DOI: 10.1186/S12982-016-0047-X  0.321
2016 Lawler PR, Akinkuolie AO, Chandler PD, Moorthy MV, Vandenburgh MJ, Schaumberg DA, Lee IM, Glynn RJ, Ridker PM, Buring JE, Mora S. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk. Circulation Research. 118: 1106-15. PMID 26951635 DOI: 10.1161/Circresaha.115.308078  0.336
2016 Kumamaru H, Gagne JJ, Glynn RJ, Setoguchi S, Schneeweiss S. Comparison of high dimensional confounder summary scores in comparative studies of newly marketed medications. Journal of Clinical Epidemiology. PMID 26931292 DOI: 10.1016/J.Jclinepi.2016.02.011  0.33
2016 Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women. Ophthalmic Epidemiology. 1-8. PMID 26786311 DOI: 10.3109/09286586.2015.1130845  0.304
2016 Lawler PR, Akinkuolie AO, Harada P, Glynn R, Ridker P, Mora S. RESIDUAL RISK AND ON-STATIN REDUCTIONS IN TRIGLYCERIDES, REMNANT CHOLESTEROL, AND VLDL LIPOPROTEINS: AN ANALYSIS FROM THE JUPITER TRIAL Journal of the American College of Cardiology. 67: 1853. DOI: 10.1016/S0735-1097(16)31854-X  0.322
2016 Wyss R, Glynn RJ, Gagne JJ. A Review of Disease Risk Scores and Their Application in Pharmacoepidemiology Current Epidemiology Reports. 3: 277-284. DOI: 10.1007/S40471-016-0088-2  0.314
2015 Mora S, Caulfield MP, Wohlgemuth J, Chen Z, Superko HR, Rowland CM, Glynn RJ, Ridker PM, Krauss RM. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The JUPITER Trial. Circulation. PMID 26408274 DOI: 10.1161/Circulationaha.115.016857  0.302
2015 Jiménez MC, Rexrode KM, Glynn RJ, Ridker PM, Gaziano JM, Sesso HD. Association Between High-Sensitivity C-Reactive Protein and Total Stroke by Hypertensive Status Among Men. Journal of the American Heart Association. 4: e002073. PMID 26391131 DOI: 10.1161/Jaha.115.002073  0.321
2015 Chiuve SE, Sandhu RK, Moorthy MV, Glynn RJ, Albert CM. Dietary Fat Intake Is Differentially Associated with Risk of Paroxysmal Compared with Sustained Atrial Fibrillation in Women. The Journal of Nutrition. 145: 2092-101. PMID 26180251 DOI: 10.3945/Jn.115.212860  0.305
2015 Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S. High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 131: 1851-60. PMID 25825410 DOI: 10.1161/Circulationaha.114.014522  0.331
2015 Kim SC, Schneeweiss S, Choudhry N, Liu J, Glynn RJ, Solomon DH. Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study. The American Journal of Medicine. 128: 653.e7-653.e16. PMID 25660249 DOI: 10.1016/J.Amjmed.2015.01.013  0.323
2015 Franklin JM, Schneeweiss S, Huybrechts KF, Glynn RJ. Evaluating possible confounding by prescriber in comparative effectiveness research. Epidemiology (Cambridge, Mass.). 26: 238-41. PMID 25643103 DOI: 10.1097/Ede.0000000000000241  0.302
2015 Kim SC, Solomon DH, Liu J, Franklin JM, Glynn RJ, Schneeweiss S. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. The American Journal of Medicine. 128: 539.e7-17. PMID 25534420 DOI: 10.1016/J.Amjmed.2014.11.025  0.332
2015 Peña JM, Aspberg S, MacFadyen J, Glynn RJ, Solomon DH, Ridker PM. Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial. Jama Internal Medicine. 175: 171-7. PMID 25437881 DOI: 10.1001/Jamainternmed.2014.6388  0.324
2015 Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM, Blanke CD, Klein EA. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. Jama Ophthalmology. 133: 17-24. PMID 25232809 DOI: 10.1001/Jamaophthalmol.2014.3478  0.31
2015 Lawler PR, Akinkuolie A, Glynn R, Ridker P, Mora S. ATHEROGENIC LIPOPROTEIN PARTICLE SUBCLASSES AND RESIDUAL CARDIOVASCULAR RISK: AN ANALYSIS OF THE JUPITER TRIAL Journal of the American College of Cardiology. 65: A1362. DOI: 10.1016/S0735-1097(15)61362-6  0.308
2014 Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB. Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study. Acta Diabetologica. 51: 1015-23. PMID 25311055 DOI: 10.1007/S00592-014-0663-2  0.339
2014 Sandhu RK, Conen D, Tedrow UB, Fitzgerald KC, Pradhan AD, Ridker PM, Glynn RJ, Albert CM. Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillation. Journal of the American Heart Association. 3: e000916. PMID 24786144 DOI: 10.1161/Jaha.114.000916  0.307
2014 Patorno E, Glynn RJ, Hernández-Díaz S, Liu J, Schneeweiss S. Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments. Epidemiology (Cambridge, Mass.). 25: 268-78. PMID 24487209 DOI: 10.1097/Ede.0000000000000069  0.327
2014 Christen WG, Glynn RJ, Manson JE, MacFadyen J, Bubes V, Schvartz M, Buring JE, Sesso HD, Gaziano JM. Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 121: 525-34. PMID 24268861 DOI: 10.1016/J.Ophtha.2013.09.038  0.323
2013 Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. Journal of the American Heart Association. 2: e000208. PMID 23900213 DOI: 10.1161/Jaha.113.000208  0.331
2013 Matsumoto C, Hanson NQ, Tsai MY, Glynn RJ, Gaziano JM, Djoussé L. Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study. Clinical Nutrition (Edinburgh, Scotland). 32: 819-23. PMID 23473794 DOI: 10.1016/J.Clnu.2013.02.006  0.319
2013 Wang SV, Gagne JJ, Glynn RJ, Schneeweiss S. Case-crossover studies of therapeutics: design approaches to addressing time-varying prognosis in elderly populations. Epidemiology (Cambridge, Mass.). 24: 375-8. PMID 23466528 DOI: 10.1097/Ede.0B013E31828Ac9Cb  0.304
2013 Winter AC, Berger K, Glynn RJ, Buring JE, Gaziano JM, Schürks M, Kurth T. Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. The American Journal of Medicine. 126: 228-35, 235.e1-2. PMID 23410563 DOI: 10.1016/J.Amjmed.2012.06.039  0.322
2013 Mitta VP, Christen WG, Glynn RJ, Semba RD, Ridker PM, Rimm EB, Hankinson SE, Schaumberg DA. C-reactive protein and the incidence of macular degeneration: pooled analysis of 5 cohorts. Jama Ophthalmology. 131: 507-13. PMID 23392454 DOI: 10.1001/Jamaophthalmol.2013.2303  0.361
2013 Petrone AB, Weir N, Hanson NQ, Glynn R, Tsai MY, Gaziano JM, Djoussé L. Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study. The American Journal of Clinical Nutrition. 97: 66-71. PMID 23193008 DOI: 10.3945/Ajcn.112.048991  0.313
2012 Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. Jama. 308: 1871-80. PMID 23162860 DOI: 10.1001/Jama.2012.14641  0.314
2012 Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE, Gaziano JM. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Jama. 308: 1751-60. PMID 23117775 DOI: 10.1001/Jama.2012.14805  0.362
2012 Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (London, England). 380: 565-71. PMID 22883507 DOI: 10.1016/S0140-6736(12)61190-8  0.324
2012 Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Christopher Roebuck M, Schneeweiss S. Association between the Part D coverage gap and adverse health outcomes. Journal of the American Geriatrics Society. 60: 1408-17. PMID 22788544 DOI: 10.1111/J.1532-5415.2012.04073.X  0.339
2012 Gagne JJ, Glynn RJ, Rassen JA, Walker AM, Daniel GW, Sridhar G, Schneeweiss S. Active safety monitoring of newly marketed medications in a distributed data network: Application of a semi-automated monitoring system Clinical Pharmacology and Therapeutics. 92: 80-86. PMID 22588606 DOI: 10.1038/Clpt.2011.369  0.303
2012 Glynn RJ, Gagne JJ, Schneeweiss S. Role of disease risk scores in comparative effectiveness research with emerging therapies. Pharmacoepidemiology and Drug Safety. 21: 138-47. PMID 22552989 DOI: 10.1002/Pds.3231  0.353
2012 Polinski JM, Schneeweiss S, Glynn RJ, Lii J, Rassen JA. Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment. Pharmacoepidemiology and Drug Safety. 21: 90-8. PMID 22552984 DOI: 10.1002/Pds.3250  0.326
2012 Polinski JM, Shrank WH, Glynn RJ, Huskamp HA, Roebuck MC, Schneeweiss S. Beneficiaries with cardiovascular disease and thePart D coverage gap. Circulation. Cardiovascular Quality and Outcomes. 5: 387-95. PMID 22511746 DOI: 10.1161/Circoutcomes.111.964866  0.315
2012 Christen WG, Glynn RJ, Sesso HD, Kurth T, Macfadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM. Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 119: 1642-9. PMID 22503302 DOI: 10.1016/J.Ophtha.2012.01.053  0.31
2012 Glynn RJ. Complex relations of genetic polymorphisms with nutritionally influenced biomarkers. The American Journal of Clinical Nutrition. 95: 1001-2. PMID 22492377 DOI: 10.3945/Ajcn.112.037655  0.355
2012 Winter AC, Schürks M, Glynn RJ, Buring JE, Gaziano JM, Berger K, Kurth T. Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. Bmj Open. 2: e000866. PMID 22447047 DOI: 10.1136/Bmjopen-2012-000866  0.361
2012 Novack V, MacFadyen J, Malhotra A, Almog Y, Glynn RJ, Ridker PM. The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 184: E367-72. PMID 22431901 DOI: 10.1503/Cmaj.111017  0.342
2012 Peña JM, MacFadyen J, Glynn RJ, Ridker PM. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. European Heart Journal. 33: 531-7. PMID 22187510 DOI: 10.1093/Eurheartj/Ehr460  0.338
2012 Fitzgerald KC, Chiuve SE, Buring JE, Ridker PM, Glynn RJ. Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism. Journal of Thrombosis and Haemostasis : Jth. 10: 189-98. PMID 22151600 DOI: 10.1111/J.1538-7836.2011.04588.X  0.317
2011 Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. American Heart Journal. 162: 106-14.e2. PMID 21742096 DOI: 10.1016/J.Ahj.2011.03.032  0.344
2011 Powell TM, Glynn RJ, Buring JE, Creager MA, Ridker PM, Pradhan AD. The relative importance of systolic versus diastolic blood pressure control and incident symptomatic peripheral artery disease in women. Vascular Medicine (London, England). 16: 239-46. PMID 21730007 DOI: 10.1177/1358863X11413166  0.32
2011 Patrick AR, Shrank WH, Glynn RJ, Solomon DH, Dormuth CR, Avorn J, Cadarette SM, Mogun H, Brookhart MA. The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 513-20. PMID 21669377 DOI: 10.1016/J.Jval.2010.10.033  0.338
2011 Conen D, Chae CU, Glynn RJ, Tedrow UB, Everett BM, Buring JE, Albert CM. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. Jama. 305: 2080-7. PMID 21610240 DOI: 10.1001/Jama.2011.659  0.337
2011 Schmidt M, Christiansen CF, Horváth-Puhó E, Glynn RJ, Rothman KJ, Sørensen HT. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism Journal of Thrombosis and Haemostasis. 9: 1326-1333. PMID 21592304 DOI: 10.1111/J.1538-7836.2011.04354.X  0.327
2011 Ridker PM, MacFadyen JG, Glynn RJ, Chasman DI. Kinesin-like protein 6 (KIF6) polymorphism and the efficacy of rosuvastatin in primary prevention. Circulation. Cardiovascular Genetics. 4: 312-7. PMID 21493817 DOI: 10.1161/Circgenetics.110.959353  0.335
2011 Christen WG, Schaumberg DA, Glynn RJ, Buring JE. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women. Archives of Ophthalmology (Chicago, Ill. : 1960). 129: 921-9. PMID 21402976 DOI: 10.1001/Archophthalmol.2011.34  0.311
2011 Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. Journal of Clinical Epidemiology. 64: 749-59. PMID 21208778 DOI: 10.1016/J.Jclinepi.2010.10.004  0.3
2011 Baer HJ, Glynn RJ, Hu FB, Hankinson SE, Willett WC, Colditz GA, Stampfer M, Rosner B. Risk factors for mortality in the nurses' health study: a competing risks analysis. American Journal of Epidemiology. 173: 319-29. PMID 21135028 DOI: 10.1093/Aje/Kwq368  0.342
2011 Terry PD, Glynn RJ, Buring JE, Sesso HD. Hypertension and risk of death from external causes in the Physicians' Health Study enrollment cohort International Journal of Public Health. 56: 231-235. DOI: 10.1007/S00038-010-0183-Y  0.318
2010 Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. The comparative safety of analgesics in older adults with arthritis. Archives of Internal Medicine. 170: 1968-76. PMID 21149752 DOI: 10.1001/Archinternmed.2010.391  0.315
2010 Flint AJ, Rexrode KM, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, Rimm EB. Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obesity Research & Clinical Practice. 4: e171-e181. PMID 21116472 DOI: 10.1016/J.Orcp.2010.01.001  0.32
2010 Ridker PM, Macfadyen JG, Nordestgaard BG, Koenig W, Kastelein JJ, Genest J, Glynn RJ. Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial for "intermediate risk". Circulation. Cardiovascular Quality and Outcomes. 3: 447-52. PMID 20736443 DOI: 10.1161/Circoutcomes.110.938118  0.36
2010 Ridker PM, Genest J, Boekholdt SM, Libby P, Gotto AM, Nordestgaard BG, Mora S, MacFadyen JG, Glynn RJ, Kastelein JJ. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (London, England). 376: 333-9. PMID 20655105 DOI: 10.1016/S0140-6736(10)60713-1  0.332
2010 Ridker PM, MacFadyen J, Libby P, Glynn RJ. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). The American Journal of Cardiology. 106: 204-9. PMID 20599004 DOI: 10.1016/J.Amjcard.2010.03.018  0.357
2010 Ridker PM, Glynn RJ. JUPITER, rosuvastatin, and the European Medicines Agency. Lancet (London, England). 375: 2071. PMID 20494436 DOI: 10.1016/S0140-6736(10)60760-X  0.364
2010 Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial. Annals of Internal Medicine. 152: 488-96, W174. PMID 20404379 DOI: 10.7326/0003-4819-152-8-201004200-00005  0.313
2010 Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 121: 1069-77. PMID 20176986 DOI: 10.1161/Circulationaha.109.906479  0.342
2010 Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and Age-Related Macular Degeneration in a Randomized Trial of Women Ophthalmology. 117: 1163-1168. PMID 20153900 DOI: 10.1016/J.Ophtha.2009.10.043  0.324
2010 Glynn RJ. Promises and limitations of mendelian randomization for evaluation of biomarkers. Clinical Chemistry. 56: 388-90. PMID 20093553 DOI: 10.1373/Clinchem.2009.142513  0.315
2010 Rassen JA, Mittleman MA, Glynn RJ, Brookhart MA, Schneeweiss S. Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention European Heart Journal. 31: 561-572. PMID 19942600 DOI: 10.1093/Eurheartj/Ehp437  0.324
2010 Glynn RJ, Koenig W, Nordestgaard BG, Shepherd J, Ridker PM. Rosuvastatin for primary prevention in older individuals with high C-reactive protein and low LDL levels: exploratory analysis of a randomized trial Annals of Internal Medicine. 152: 488. DOI: 10.1059/0003-4819-152-8-201004200-00005  0.327
2009 Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circulation. Cardiovascular Quality and Outcomes. 2: 616-23. PMID 20031900 DOI: 10.1161/Circoutcomes.109.848473  0.328
2009 Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC, Rimm EB. Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring, Md.). 18: 377-83. PMID 19629058 DOI: 10.1038/Oby.2009.223  0.323
2009 Glynn RJ, Rosner B, Christen WG. Evaluation of risk factors for cataract types in a competing risks framework. Ophthalmic Epidemiology. 16: 98-106. PMID 19353398 DOI: 10.1080/09286580902737532  0.332
2009 Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J, Brookhart MA. Statin adherence and risk of accidents: a cautionary tale. Circulation. 119: 2051-7. PMID 19349320 DOI: 10.1161/Circulationaha.108.824151  0.301
2009 Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. The New England Journal of Medicine. 360: 1851-61. PMID 19329822 DOI: 10.1056/Nejmoa0900241  0.333
2009 Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (London, England). 373: 1175-82. PMID 19329177 DOI: 10.1016/S0140-6736(09)60447-5  0.318
2009 Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Archives of Internal Medicine. 169: 335-41. PMID 19237716 DOI: 10.1001/Archinternmed.2008.574  0.311
2009 Lunt M, Solomon D, Rothman K, Glynn R, Hyrich K, Symmons DP, Stürmer T. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. American Journal of Epidemiology. 169: 909-17. PMID 19153216 DOI: 10.1093/Aje/Kwn391  0.303
2009 Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin Trial Obstetrical & Gynecological Survey. 64: 596-597. DOI: 10.1097/01.Ogx.0000358018.78512.A1  0.324
2008 Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, Brookhart MA. Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. American Journal of Epidemiology. 169: 273-84. PMID 19033525 DOI: 10.1093/Aje/Kwn299  0.311
2008 Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the Prevention of Cardiovascular Disease in Men : The Physicians' Health Study II Randomized Controlled Trial Jama. 300: 2123-2133. PMID 18997197 DOI: 10.1001/Jama.2008.600  0.333
2008 Lin J, Glynn RJ, Rifai N, Manson JE, Ridker PM, Nathan DM, Schaumberg DA. Inflammation and Progressive Nephropathy in Type 1 Diabetes in the Diabetes Control and Complications Trial Diabetes Care. 31: 2338-2343. PMID 18796620 DOI: 10.2337/Dc08-0277  0.323
2008 Solomon DH, Glynn RJ, Rothman KJ, Schneeweiss S, Setoguchi S, Mogun H, Avorn J, Stürmer T. Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis and Rheumatism. 59: 1097-104. PMID 18668605 DOI: 10.1002/Art.23911  0.371
2008 Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH. Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. American Heart Journal. 156: 31-6. PMID 18585494 DOI: 10.1016/J.Ahj.2008.03.021  0.343
2008 Everett BM, Glynn RJ, Danielson E, Ridker PM. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: A prespecified subgroup analysis of a community-based, randomized, open-label trial Clinical Therapeutics. 30: 661-672. PMID 18498915 DOI: 10.1016/J.Clinthera.2008.04.013  0.31
2008 Rao RS, Glickman ME, Glynn RJ. Stopping rules for surveys with multiple waves of nonrespondent follow-up. Statistics in Medicine. 27: 2196-213. PMID 17886234 DOI: 10.1002/Sim.3063  0.366
2008 Glynn RJ, Ridker PM, Zee RYL, Buring JE, Goldhaber SZ. Response to letter regarding article, "Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: Report from the women's health study" Circulation. 117: e313. DOI: 10.1161/Circulationaha.107.756437  0.304
2007 Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. The American Journal of Cardiology. 100: 1659-64. PMID 18036365 DOI: 10.1016/J.Amjcard.2007.09.072  0.306
2007 Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Annals of Internal Medicine. 147: 525-533. PMID 17938390 DOI: 10.7326/0003-4819-147-8-200710160-00004  0.356
2007 Stürmer T, Glynn RJ, Rothman KJ, Avorn J, Schneeweiss S. Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information Medical Care. 45: S158-S165. PMID 17909375 DOI: 10.1097/Mlr.0B013E318070C045  0.317
2007 Schneeweiss S, Patrick AR, Stürmer T, Brookhart MA, Avorn J, Maclure M, Rothman KJ, Glynn RJ. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results Medical Care. 45: S131-S142. PMID 17909372 DOI: 10.1097/Mlr.0B013E318070C08E  0.36
2007 Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age. The American Journal of Cardiology. 100: 1061-7. PMID 17884362 DOI: 10.1016/J.Amjcard.2007.04.052  0.32
2006 Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 114: 2619-26. PMID 17116764 DOI: 10.1161/Circulationaha.106.660043  0.332
2006 Solomon DH, Avorn J, Stürmer T, Glynn RJ, Mogun H, Schneeweiss S. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis and Rheumatism. 54: 1378-89. PMID 16645966 DOI: 10.1002/Art.21887  0.33
2006 Glynn RJ, Schneeweiss S, Stürmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic & Clinical Pharmacology & Toxicology. 98: 253-9. PMID 16611199 DOI: 10.1111/J.1742-7843.2006.Pto_293.X  0.302
2006 Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect American Journal of Epidemiology. 163: 262-270. PMID 16371515 DOI: 10.1093/Aje/Kwj047  0.304
2005 Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. American Journal of Epidemiology. 162: 975-82. PMID 16207808 DOI: 10.1093/Aje/Kwi309  0.335
2005 Kurth T, Hennekens CH, Stürmer T, Sesso HD, Glynn RJ, Buring JE, Gaziano JM. Analgesic use and risk of subsequent hypertension in apparently healthy men. Archives of Internal Medicine. 165: 1903-9. PMID 16157836 DOI: 10.1001/Archinte.165.16.1903  0.322
2005 Stürmer T, Schneeweiss S, Avorn J, Glynn RJ. Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. American Journal of Epidemiology. 162: 279-89. PMID 15987725 DOI: 10.1093/Aje/Kwi192  0.315
2005 Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, Fischer MA, Glynn RJ. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives Hypertension. 46: 273-279. PMID 15983239 DOI: 10.1161/01.Hyp.0000172753.96583.E1  0.323
2005 Bowman TS, Sesso HD, Glynn RJ, Gaziano JM. JNC 7 category and risk of cardiovascular death in men: are there differences by age? The American Journal of Geriatric Cardiology. 14: 126-31; quiz 132-3. PMID 15886538 DOI: 10.1111/J.1076-7460.2005.03809.X  0.357
2005 Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial Circulation. 111: 2446-2453. PMID 15867184 DOI: 10.1161/01.Cir.0000165064.31505.3B  0.312
2005 Stürmer T, Schneeweiss S, Brookhart MA, Rothman KJ, Avorn J, Glynn RJ. Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: Nonsteroidal antiinflammatory drugs and short-term mortality in the elderly American Journal of Epidemiology. 161: 891-898. PMID 15840622 DOI: 10.1093/Aje/Kwi106  0.345
2005 Wang PS, Schneeweiss S, Brookhart MA, Glynn RJ, Mogun H, Patrick AR, Avorn J. Suboptimal antidepressant use in the elderly. Journal of Clinical Psychopharmacology. 25: 118-26. PMID 15738742 DOI: 10.1097/01.Jcp.0000155819.67209.E5  0.318
2005 Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 53: 2883-92. PMID 15504969 DOI: 10.2337/Diabetes.53.11.2883  0.307
2005 Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 110: e7-12. PMID 15249517 DOI: 10.1161/01.Cir.0000135583.40730.21  0.328
2005 SCHNEEWEISS S, MACLURE M, DORMUTH C, GLYNN R, CANNING C, AVORN J. Clinical and economic consequences of formulary restrictions for three leading proton pump inhibitors Clinical Pharmacology & Therapeutics. 77: P1-P1. DOI: 10.1016/J.Clpt.2004.11.008  0.303
2004 Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ. Hemoglobin A1c level and future cardiovascular events among women. Archives of Internal Medicine. 164: 757-61. PMID 15078645 DOI: 10.1001/Archinte.164.7.757  0.326
2004 Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ. Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS). Circulation. 109: 1623-9. PMID 15023883 DOI: 10.1161/01.Cir.0000124488.06377.77  0.341
2004 Rao RS, Glickman ME, Glynn RJ. Use of Covariates and Survey Wave to Adjust for Nonresponse Biometrical Journal. 46: 579-588. DOI: 10.1002/Bimj.200310049  0.394
2003 Schneeweiss S, Soumerai SB, Maclure M, Dormuth C, Walker AM, Glynn RJ. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers Clinical Pharmacology and Therapeutics. 74: 388-400. PMID 14534526 DOI: 10.1016/S0009-9236(03)00227-3  0.302
2003 Chae CU, Albert CM, Glynn RJ, Guralnik JM, Curhan GC. Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. The American Journal of Cardiology. 92: 682-6. PMID 12972106 DOI: 10.1016/S0002-9149(03)00822-1  0.329
2003 Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, Gaziano JM. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs Circulation. 108: 1191-1195. PMID 12939216 DOI: 10.1161/01.Cir.0000087593.07533.9B  0.346
2003 Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, ... ... Glynn RJ, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. The New England Journal of Medicine. 348: 1425-34. PMID 12601075 DOI: 10.1056/Nejmoa035029  0.316
2003 Sesso HD, Gaziano JM, VanDenburgh M, Hennekens CH, Glynn RJ, Buring JE. Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study. Controlled Clinical Trials. 23: 686-702. PMID 12505246 DOI: 10.1016/S0197-2456(02)00235-0  0.346
2003 Winkelmayer WC, Glynn RJ, Mittleman MA, Levin R, Pliskin JS, Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: a propensity score approach. Journal of the American Society of Nephrology : Jasn. 13: 2353-62. PMID 12191980 DOI: 10.1097/01.Asn.0000025785.41314.76  0.31
2002 Avorn J, Benner J, Ford I, Ganz DA, Gaw A, Glynn RJ, Jackson J, Lagaay AM, Schneeweiss S, Walley T, Wang PS. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Controlled Clinical Trials. 23: 757-73. PMID 12505250 DOI: 10.1016/S0197-2456(02)00228-3  0.365
2002 Wang PS, Glynn RJ, Ganz DA, Schneeweiss S, Levin R, Avorn J. Clozapine use and risk of diabetes mellitus. Journal of Clinical Psychopharmacology. 22: 236-43. PMID 12006892 DOI: 10.1097/00004714-200206000-00002  0.328
2002 Solomon DH, Ganz DA, Avorn J, Glynn RJ, Knight EL, Gibson CM, Stone PH. Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. Journal of Clinical Epidemiology. 55: 121-8. PMID 11809349 DOI: 10.1016/S0895-4356(01)00427-9  0.321
2002 Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension. 39: 105-10. PMID 11799087 DOI: 10.1161/Hy1201.097199  0.326
2001 Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 38: 1178-84. PMID 11728948 DOI: 10.1053/Ajkd.2001.29207  0.306
2001 Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. American Journal of Epidemiology. 154: 854-64. PMID 11682368 DOI: 10.1093/Aje/154.9.854  0.301
2001 Glynn RJ, Knight EL, Levin R, Avorn J. Paradoxical relations of drug treatment with mortality in older persons. Epidemiology (Cambridge, Mass.). 12: 682-9. PMID 11679797 DOI: 10.1097/00001648-200111000-00017  0.308
2001 Solomon DH, Stone PH, Glynn RJ, Ganz DA, Gibson CM, Tracy R, Avorn J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy Journal of the American College of Cardiology. 38: 969-976. PMID 11583866 DOI: 10.1016/S0735-1097(01)01503-0  0.328
2001 Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation. 104: 393-8. PMID 11468199 DOI: 10.1161/Hc2901.093115  0.306
2001 Christen WG, Ajani UA, Schaumberg DA, Glynn RJ, Manson JE, Hennekens CH. Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I. Archives of Ophthalmology (Chicago, Ill. : 1960). 119: 405-12. PMID 11231774 DOI: 10.1001/Archopht.119.3.405  0.335
2001 Christen WG, Ajani U, Schaumberg D, Glynn R, Manson J, Hennekens C, Fine IH. Aspirin use and risk of cataract in posttrial follow-up Evidence-Based Eye Care. 2: 228-229. DOI: 10.1097/00132578-200110000-00021  0.302
2001 Benner J, Federman A, Smitten A, Duty S, Glynn R, Avorn J. PCV24: BEYOND THE FIRST YEAR: PATTERNS AND PREDICTORS OF LONG-TERM STATIN UTILIZATION Value in Health. 4: 104. DOI: 10.1046/J.1524-4733.2001.40202-98.X  0.322
2000 Ganz DA, Glynn RJ, Mogun H, Knight EL, Bohn RL, Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism Journal of General Internal Medicine. 15: 776-781. PMID 11119169 DOI: 10.1046/J.1525-1497.2000.91022.X  0.321
2000 Knight EL, Glynn RJ, Levin R, Ganz DA, Avorn J. Failure of evidence-based medicine in the treatment of hypertension in older patients Journal of General Internal Medicine. 15: 702-709. PMID 11089713 DOI: 10.1046/J.1525-1497.2000.91020.X  0.314
2000 Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Archives of Internal Medicine. 160: 422-34. PMID 10695683 DOI: 10.1001/Archinte.160.4.422  0.311
2000 Stürmer T, Glynn RJ, Kliebsch U, Brenner H. Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. Journal of Clinical Epidemiology. 53: 57-64. PMID 10693904 DOI: 10.1016/S0895-4356(99)00137-7  0.311
2000 Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Manson JE, Buring JE, Hennekens CH. Baseline self-reported cataract and subsequent mortality in Physicians' Health Study I Ophthalmic Epidemiology. 7: 115-125. DOI: 10.1076/0928-6586(200006)721-Zft115  0.333
1999 Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Agreement between drug treatment data and a discharge diagnosis of diabetes mellitus in the elderly. American Journal of Epidemiology. 149: 541-9. PMID 10084243 DOI: 10.1093/Oxfordjournals.Aje.A009850  0.303
1999 Christen WG, Ajani UA, Glynn RJ, Manson JE, Schaumberg DA, Chew EC, Buring JE, Hennekens CH. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. American Journal of Epidemiology. 149: 476-84. PMID 10067908 DOI: 10.1093/Oxfordjournals.Aje.A009836  0.342
1999 Christen WG, Manson JE, Glynn RJ, Ajani UA, Schaumberg DA, Sperduto RD, Buring JE, Hennekens CH. Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians. Ophthalmic Epidemiology. 5: 133-42. PMID 9805346 DOI: 10.1076/Opep.5.3.133.8368  0.309
1998 Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin R, Avorn J. Patient Noncompliance in the Managed Care Setting: The Case of Medical Therapy for Glaucoma Medical Care. 36: 357-369. PMID 9520960 DOI: 10.1097/00005650-199803000-00012  0.304
1997 Gurwitz JH, Kalish SC, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Thiazide diuretics and the initiation of anti-gout therapy. Journal of Clinical Epidemiology. 50: 953-9. PMID 9291881 DOI: 10.1016/S0895-4356(97)00101-7  0.331
1997 Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. American Journal of Hypertension. 10: 697-704. PMID 9234822 DOI: 10.1016/S0895-7061(97)00056-3  0.336
1995 Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study. Archives of Internal Medicine. 154: 2649-57. PMID 7993148 DOI: 10.1001/Archinte.1994.00420230032005  0.314
1995 Monane M, Glynn RJ, Gurwitz JH, Bohn RL, Levin R, Avorn J. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension (Dallas, Tex. : 1979). 25: 1045-51. PMID 7737714 DOI: 10.1161/01.Hyp.25.5.1045  0.329
1995 Glynn RJ, Brock DB, Harris T, Havlik RJ, Chrischilles EA, Ostfeld AM, Taylor JO, Hennekens CH. Use of Antihypertensive Drugs and Trends in Blood Pressure in the Elderly Archives of Internal Medicine. 155: 1855-1860. PMID 7677551 DOI: 10.1001/Archinte.1995.00430170043005  0.321
1995 O’Donnell CJ, Ridker PM, Berger K, LaMotte F, Glynn RJ, Manson JE, Hennekens CH. 901-79 Borderline Isolated Systolic Hypertension and Subsequent Risk of Cardiovascular Disease Journal of the American College of Cardiology. 25: 24A. DOI: 10.1016/0735-1097(95)91556-D  0.339
1994 Manson JE, Christen WG, Seddon JM, Glynn RJ, Hennekens CH. A Prospective Study of Alcohol Consumption and Risk of Cataract American Journal of Preventive Medicine. 10: 156-161. DOI: 10.1016/S0749-3797(18)30612-3  0.311
1993 Avorn J, Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Everitt DE, Gilden D, Choodnovskiy I. Adverse Pulmonary Effects of Topical ?? Blockers Used in the Treatment of Glaucoma Journal of Glaucoma. 2: 158???165. DOI: 10.1097/00061198-199300230-00003  0.34
1993 Christen W, Manson J, Seddon J, Glynn R, Buring J, Rosner B, Hennekens C. A prospective study of cigarette smoking and risk of cataract in men Journal of Safety Research. 24: 129-130. DOI: 10.1001/Jama.1992.03490080063025  0.319
1992 de Labry LO, Glynn RJ, Levenson MR, Hermos JA, LoCastro JS, Vokonas PS. Alcohol consumption and mortality in an American male population: recovering the U-shaped curve--findings from the normative Aging Study. Journal of Studies On Alcohol. 53: 25-32. PMID 1556854 DOI: 10.15288/Jsa.1992.53.25  0.303
1991 Glynn RJ, Seddon JM, Krug JH, Sahagian CR, Chiavelli ME, Campion EW. Falls in elderly patients with glaucoma. Archives of Ophthalmology (Chicago, Ill. : 1960). 109: 205-10. PMID 1993029 DOI: 10.1001/Archopht.1991.01080020051041  0.323
1991 Glynn RJ, Schein OD, Seddon JM, Poggio EC, Goodfellow JR, Scardino VA, Shannon MJ, Kenyon KR. The incidence of ulcerative keratitis among aphakic contact lens wearers in New England. Archives of Ophthalmology (Chicago, Ill. : 1960). 109: 104-7. PMID 1987926 DOI: 10.1001/Archopht.1991.01080010106041  0.311
1990 Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology. 96: 1716-21. PMID 2622616 DOI: 10.1016/S0161-6420(89)32659-5  0.302
1990 Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Archives of Ophthalmology (Chicago, Ill. : 1960). 108: 1274-80. PMID 2400347 DOI: 10.1001/Archopht.1990.01070110090031  0.319
1990 de Labry LO, Campion EW, Glynn RJ, Vokonas PS. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. Journal of Clinical Epidemiology. 43: 153-7. PMID 2303845 DOI: 10.1016/0895-4356(90)90178-R  0.327
1990 Austin KL, Palmer JR, Seddon JM, Glynn RJ, Rosenberg L, Gragoudas ES, Kaufman DW, Shapiro S. Case-control study of idiopathic retinal detachment. International Journal of Epidemiology. 19: 1045-50. PMID 2083988 DOI: 10.1093/Ije/19.4.1045  0.323
1982 Glynn RJ, Rosner B, Silbert JE. Changes in cholesterol and triglyceride as predictors of ischemic heart disease in men. Circulation. 66: 724-31. PMID 7116589 DOI: 10.1161/01.Cir.66.4.724  0.317
Low-probability matches (unlikely to be authored by this person)
2017 Ridker PM, MacFadyen JG, Everett BM, Libby P, Thuren T, Glynn RJ. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial. Lancet (London, England). PMID 29146124 DOI: 10.1016/S0140-6736(17)32814-3  0.3
2019 Rothman AM, MacFadyen J, Thuren T, Webb A, Harrison DG, Guzik TJ, Libby P, Glynn RJ, Ridker PM. Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11913. PMID 31884854 DOI: 10.1161/Hypertensionaha.119.13642  0.3
2015 Dougan MM, Hankinson SE, Vivo ID, Tworoger SS, Glynn RJ, Michels KB. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. International Journal of Cancer. Journal International Du Cancer. 137: 625-37. PMID 25641700 DOI: 10.1002/Ijc.29427  0.3
1999 Gaziano JM, Hennekens CH, Godfried SL, Sesso HD, Glynn RJ, Breslow JL, Buring JE. Type of alcoholic beverage and risk of myocardial infarction. The American Journal of Cardiology. 83: 52-7. PMID 10073785 DOI: 10.1016/S0002-9149(98)00782-6  0.3
2000 Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (Dallas, Tex. : 1979). 36: 801-7. PMID 11082146 DOI: 10.1161/01.Hyp.36.5.801  0.299
2011 Patrick AR, Schneeweiss S, Brookhart MA, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiology and Drug Safety. 20: 551-9. PMID 21394812 DOI: 10.1002/Pds.2098  0.299
2009 Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, Ridker PM. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women's Genome Health Study. Circulation. Cardiovascular Genetics. 2: 57-62. PMID 20031567 DOI: 10.1161/Circgenetics.108.801969  0.298
2018 Dugani S, Farukhi Z, Damilig K, Callachan E, Murad W, Elfatih A, Yusef S, Al Zaabi E, Glynn R, Moorthy M, Mora B, Alawadhi A, Saleh A, Al-Mulla A, Alsheikh-Ali A. Prevalence of Cardiovascular Risk Factors among Patients Presenting with Premature Myocardial Infarction in the Middle East Journal of Clinical Lipidology. 12: 523-525. DOI: 10.1016/J.Jacl.2018.03.014  0.297
2001 Schaumberg DA, Glynn RJ, Christen WG, Ajani UA, Stürmer T, Hennekens CH. A prospective study of blood pressure and risk of cataract in men. Annals of Epidemiology. 11: 104-10. PMID 11164126 DOI: 10.1016/S1047-2797(00)00178-2  0.297
2014 Stürmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. Journal of Internal Medicine. 275: 570-80. PMID 24520806 DOI: 10.1111/Joim.12197  0.297
2010 Everett BM, Glynn RJ, MacFadyen JG, Ridker PM. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Circulation. 121: 143-50. PMID 20026779 DOI: 10.1161/Circulationaha.109.874834  0.297
2006 Stürmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods Journal of Clinical Epidemiology. 59: 437.e1-437.e24. PMID 16632131 DOI: 10.1016/J.Jclinepi.2005.07.004  0.297
2003 Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations Health Services Research. 38: 1103-1120. PMID 12968819 DOI: 10.1111/1475-6773.00165  0.296
2006 Setoguchi S, Glynn RJ, Avorn J, Mogun H, Schneeweiss S. Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation. 115: 27-33. PMID 17179016 DOI: 10.1161/Circulationaha.106.650176  0.296
2020 Spoendlin J, Desai RJ, Franklin JM, Glynn RJ, Payne E, Schneeweiss S. Using Healthcare Databases to Replicate Trial Findings for Supplemental Indications: Adalimumab in Patients with Ulcerative Colitis. Clinical Pharmacology and Therapeutics. PMID 32320482 DOI: 10.1002/Cpt.1861  0.296
1999 Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. Journal of Clinical Epidemiology. 52: 781-90. PMID 10465323 DOI: 10.1016/S0895-4356(99)00055-4  0.296
2017 Lawler PR, Akinkuolie AO, Harada P, Glynn RJ, Chasman DI, Ridker PM, Mora S. Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very-Low-Density Lipoproteins. Journal of the American Heart Association. 6. PMID 29223956 DOI: 10.1161/Jaha.117.007402  0.295
1987 Campion E, Glynn R, Delabry L. Asymptomatic Hyperuricemia. Risks and Consequences in the Normative Aging Study Journal of Urology. 138: 686-687. DOI: 10.1016/S0022-5347(17)43321-0  0.295
2011 Rassen JA, Glynn RJ, Brookhart MA, Schneeweiss S. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. American Journal of Epidemiology. 173: 1404-13. PMID 21602301 DOI: 10.1093/Aje/Kwr001  0.295
1989 Schein OD, Glynn RJ, Poggio EC, Seddon JM, Kenyon KR. The relative risk of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. A case-control study. Microbial Keratitis Study Group. The New England Journal of Medicine. 321: 773-8. PMID 2671733 DOI: 10.1056/Nejm198909213211201  0.295
2016 Dugani SB, Akinkuolie AO, Paynter N, Glynn RJ, Ridker PM, Mora S. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. 1: 136-145. PMID 27347563 DOI: 10.1001/Jamacardio.2016.0096  0.295
2016 Akinkuolie AO, Glynn RJ, Padmanabhan L, Ridker PM, Mora S. Circulating N-Linked Glycoprotein Side-Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial. Journal of the American Heart Association. 5. PMID 27413042 DOI: 10.1161/Jaha.116.003822  0.295
2003 Sesso HD, Chen RS, L'Italien GJ, Lapuerta P, Lee WC, Glynn RJ. Blood pressure lowering and life expectancy based on a Markov model of cardiovascular events. Hypertension. 42: 885-90. PMID 14557283 DOI: 10.1161/01.Hyp.0000097602.67134.4D  0.294
2012 Desai NR, Shrank WH, Antman E, Avorn J, Glynn R, Levin R, Choudhry N. THE RELATIVE BENEFIT OF FULL PRESCRIPTION COVERAGE VERSUS USUAL PRESCRIPTION COVERAGE IN PATIENTS UNDERGOING PCI: AN ANALYSIS FROM THE MI FREEE TRIAL Journal of the American College of Cardiology. 59: E511. DOI: 10.1016/S0735-1097(12)60512-9  0.294
1990 Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology. 97: 769-77. PMID 2374681 DOI: 10.1016/S0161-6420(90)32512-5  0.294
2015 Kim SC, Glynn RJ, Giovannucci E, Hernández-Díaz S, Liu J, Feldman S, Karlson EW, Schneeweiss S, Solomon DH. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Annals of the Rheumatic Diseases. 74: 1360-7. PMID 24618265 DOI: 10.1136/Annrheumdis-2013-204993  0.294
2010 Brookhart MA, Stürmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: challenges and potential approaches. Medical Care. 48: S114-20. PMID 20473199 DOI: 10.1097/Mlr.0B013E3181Dbebe3  0.294
1996 Stürmer T, Glynn RJ, Field TS, Taylor JO, Hennekens CH. Aspirin use and cognitive function in the elderly. American Journal of Epidemiology. 143: 683-91. PMID 8651230 DOI: 10.1093/Oxfordjournals.Aje.A008801  0.294
2002 Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors New England Journal of Medicine. 346: 822-829. PMID 11893794 DOI: 10.1056/Nejmsa003087  0.293
2003 Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 108: 161-5. PMID 12835213 DOI: 10.1161/01.Cir.0000080289.72166.Cf  0.293
2010 Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. Bmj (Clinical Research Ed.). 341: c5702. PMID 21051774 DOI: 10.1136/Bmj.C5702  0.293
2014 Kim SC, Schneeweiss S, Glynn RJ, Doherty M, Goldfine AB, Solomon DH. Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. Annals of the Rheumatic Diseases. PMID 24919467 DOI: 10.1136/Annrheumdis-2014-205216  0.292
1992 Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, Glynn RJ, Ostfeld AM, Guralnik JM. Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly Journals of Gerontology. 47. PMID 1512428 DOI: 10.1093/Geronj/47.5.M137  0.292
2007 Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Performance of propensity score calibration - A simulation study American Journal of Epidemiology. 165: 1110-1118. PMID 17395595 DOI: 10.1093/Aje/Kwm074  0.292
2018 Krumme AA, Glynn RJ, Schneeweiss S, Gagne JJ, Dougherty JS, Brill G, Choudhry NK. Medication Synchronization Programs Improve Adherence To Cardiovascular Medications And Health Care Use. Health Affairs (Project Hope). 37: 125-133. PMID 29309231 DOI: 10.1377/Hlthaff.2017.0881  0.292
2010 Christen WG, Glynn RJ, Sesso HD, Kurth T, MacFadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM. Age-related cataract in a randomized trial of vitamins E and C in men. Archives of Ophthalmology (Chicago, Ill. : 1960). 128: 1397-405. PMID 21060040 DOI: 10.1001/Archophthalmol.2010.266  0.291
2013 Tokede OA, Petrone AB, Hanson NQ, Tsai MY, Weir NA, Glynn RJ, Gaziano JM, Djoussé L. Plasma phospholipid trans fatty acids and risk of heart failure. The American Journal of Clinical Nutrition. 97: 698-705. PMID 23446892 DOI: 10.3945/Ajcn.112.050120  0.291
2010 Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. American Journal of Epidemiology. 172: 843-54. PMID 20716704 DOI: 10.1093/Aje/Kwq198  0.291
2017 Ridker PM, Lonn E, Paynter NP, Glynn R, Yusuf S. Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses from the Contemporary JUPITER and HOPE-3 Randomized Trials. Circulation. PMID 28385949 DOI: 10.1161/Circulationaha.117.028271  0.291
2007 Stürmer T, Schneeweiss S, Rothman KJ, Avorn J, Glynn RJ. Stürmer et al. respond to "propensity score methods in epidemiology" American Journal of Epidemiology. 165: 1122-1123. DOI: 10.1093/Aje/Kwm068  0.291
2014 Sesso HD, Christen WG, Bubes V, Manson JE, Glynn RJ, Buring JE, Gaziano JM. Abstract 3245: Multivitamins and cancer in the Physicians’ Health Study II: Expanded analyses and insights Cancer Research. 74: 3245-3245. DOI: 10.1158/1538-7445.Am2014-3245  0.291
2017 Ridker PM, Tardif JC, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJ, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, et al. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine. PMID 28304227 DOI: 10.1056/Nejmoa1614062  0.291
1998 Bohn RL, Avorn J, Glynn RJ, Choodnovskiy I, Haschemeyer R, Aledort LM. Prophylactic Use of Factor VIII: an Economic Evaluation Thrombosis and Haemostasis. 79: 932-937. DOI: 10.1055/S-0037-1615097  0.291
1997 Monane M, Gurwitz JH, Bohn RL, Glynn RJ, Levin R, Monette J, Avorn J. The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis. Journal of the American Geriatrics Society. 45: 71-5. PMID 8994491 DOI: 10.1111/J.1532-5415.1997.Tb00981.X  0.29
2006 Albert MA, Glynn RJ, Wolfert RL, Ridker PM. The effect of statin therapy on lipoprotein associated phospholipase A2 levels. Atherosclerosis. 182: 193-8. PMID 15982658 DOI: 10.1016/J.Atherosclerosis.2005.05.006  0.29
1998 Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 97: 2007-11. PMID 9610529 DOI: 10.1161/01.Cir.97.20.2007  0.29
2007 Wolin KY, Lee IM, Colditz GA, Glynn RJ, Fuchs C, Giovannucci E. Leisure-time physical activity patterns and risk of colon cancer in women. International Journal of Cancer. 121: 2776-81. PMID 17722094 DOI: 10.1002/Ijc.23009  0.29
2001 Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J. Predictors of uncontrolled hypertension in ambulatory patients. Hypertension (Dallas, Tex. : 1979). 38: 809-14. PMID 11641291 DOI: 10.1161/Hy0901.091681  0.29
2005 Schneeweiss S, Glynn RJ, Tsai EH, Avorn J, Solomon DH. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (Cambridge, Mass.). 16: 17-24. PMID 15613941 DOI: 10.1097/01.Ede.0000147164.11879.B5  0.29
2006 Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. Journal of Thrombosis and Haemostasis : Jth. 4: 2199-203. PMID 16869933 DOI: 10.1111/J.1538-7836.2006.02140.X  0.29
2010 Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. Journal of the American College of Cardiology. 55: 1266-73. PMID 20206456 DOI: 10.1016/J.Jacc.2010.01.020  0.29
1985 Glynn RJ, Campion EW, Bouchard GR, Silbert JE. The Development Of Benign Prostatic Hyperplasia Among Volunteers In The Normative Aging Study American Journal of Epidemiology. 121: 78-90. DOI: 10.1093/Oxfordjournals.Aje.A113986  0.29
2016 Wang SV, Franklin JM, Glynn RJ, Schneeweiss S, Eddings W, Gagne JJ. Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study. Bmj (Clinical Research Ed.). 353: i2607. PMID 27221664 DOI: 10.1136/Bmj.I2607  0.29
2004 Stürmer T, Glynn RJ. S20.3: Risk for Colorectal Cancer After Initiation of Regular Nonsteroidal Anti‐inflammatory Drug Use: Post‐Trial Follow‐up Data from the Physicians' Health Study Biometrical Journal. 46: 43-43. DOI: 10.1002/Bimj.200490246  0.289
1993 Glynn RJ, Gurwitz JH, Bohn RL, Monane M, Choodnovskiy I, Avorn J. Old age and race as determinants of initiation of glaucoma therapy. American Journal of Epidemiology. 138: 395-406. PMID 8213745 DOI: 10.1093/Oxfordjournals.Aje.A116872  0.289
2005 Scranton RE, Sesso HD, Glynn RJ, Levenson JW, Stedman M, Gagnon D, Gaziano JM. Characteristics associated with differences in reported versus measured total cholesterol among male physicians. The Journal of Primary Prevention. 26: 51-61. PMID 15976930 DOI: 10.1007/S10935-004-0991-Z  0.289
2017 Bykov K, Schneeweiss S, Glynn RJ, Mittleman MA, Bates DW, Gagne JJ. Updating the Evidence of the Interaction Between Clopidogrel and CYP2C19-Inhibiting Selective Serotonin Reuptake Inhibitors: A Cohort Study and Meta-Analysis. Drug Safety. PMID 28623527 DOI: 10.1007/S40264-017-0556-8  0.289
2020 Fralick M, Colacci M, Odutayo A, Siemieniuk R, Glynn RJ. Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis. Journal of Diabetes and Its Complications. 107704. PMID 32888788 DOI: 10.1016/J.Jdiacomp.2020.107704  0.289
2017 Wyss R, Hansen BB, Ellis AR, Gagne JJ, Desai RJ, Glynn RJ, Stürmer T. The "Dry-Run" Analysis: A Method for Evaluating Risk Scores for Confounding Control. American Journal of Epidemiology. 1-11. PMID 28338910 DOI: 10.1093/Aje/Kwx032  0.288
2017 Wei EK, Colditz GA, Giovannucci EL, Wu K, Glynn RJ, Fuchs CS, Stampfer M, Willett W, Ogino S, Rosner B. A Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data From the Nurses' Health Study. American Journal of Epidemiology. PMID 28073766 DOI: 10.1093/Aje/Kww183  0.288
1997 O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson JE, Hennekens CH. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation. 95: 1132-7. PMID 9054841 DOI: 10.1161/01.Cir.95.5.1132  0.288
2006 Winkelmayer WC, Benner JS, Glynn RJ, Schneeweiss S, Wang PS, Brookhart MA, Levin R, Jackson JD, Avorn J. Assessing health state utilities in elderly patients at cardiovascular risk. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 26: 247-54. PMID 16751323 DOI: 10.1177/0272989X06288685  0.288
2012 Rassen JA, Glynn RJ, Rothman KJ, Setoguchi S, Schneeweiss S. Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses. Pharmacoepidemiology and Drug Safety. 21: 697-709. PMID 22162077 DOI: 10.1002/Pds.2256  0.288
2012 Kesselheim AS, Robertson CT, Myers JA, Rose SL, Gillet V, Ross KM, Glynn RJ, Joffe S, Avorn J. A randomized study of how physicians interpret research funding disclosures. The New England Journal of Medicine. 367: 1119-27. PMID 22992075 DOI: 10.1056/Nejmsa1202397  0.288
2001 Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. The American Journal of Psychiatry. 158: 892-8. PMID 11384896 DOI: 10.1176/Appi.Ajp.158.6.892  0.288
2009 Schneeweiss S, Glynn RJ, Avorn J, Mamdani M, Mogun H, Solomon DH. NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib Pharmacoepidemiology and Drug Safety. 18: 1134-1142. PMID 19844943 DOI: 10.1002/Pds.1826  0.288
2012 Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiology and Drug Safety. 21: 69-80. PMID 22552982 DOI: 10.1002/Pds.3263  0.288
2008 Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. Journal of the American College of Cardiology. 51: 1247-54. PMID 18371553 DOI: 10.1016/J.Jacc.2007.10.063  0.287
2012 Lunt M, Glynn RJ, Rothman KJ, Avorn J, Stürmer T. Propensity score calibration in the absence of surrogacy. American Journal of Epidemiology. 175: 1294-302. PMID 22688682 DOI: 10.1093/Aje/Kwr463  0.287
2017 Lin KJ, Singer DE, Glynn RJ, Murphy SN, Lii J, Schneeweiss S. Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data. Clinical Pharmacology and Therapeutics. PMID 28865143 DOI: 10.1002/Cpt.861  0.287
1997 Corti MC, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, Havlik RJ. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Annals of Internal Medicine. 126: 753-60. PMID 9148647 DOI: 10.7326/0003-4819-126-10-199705150-00001  0.286
1994 Seddon JM, Christen WG, Manson JE, LaMotte FS, Glynn RJ, Buring JE, Hennekens CH. The use of vitamin supplements and the risk of cataract among US male physicians. American Journal of Public Health. 84: 788-92. PMID 8179050 DOI: 10.2105/Ajph.84.5.788  0.286
1996 Glynn RJ, Buring JE. Ways of measuring rates of recurrent events. Bmj (Clinical Research Ed.). 312: 364-7. PMID 8611837 DOI: 10.1136/Bmj.312.7027.364  0.286
2019 Connolly JG, Schneeweiss S, Glynn RJ, Gagne JJ. Quantifying bias reduction with fixed-duration versus all-available covariate assessment periods. Pharmacoepidemiology and Drug Safety. PMID 30786103 DOI: 10.1002/Pds.4729  0.286
2007 Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2391-7. PMID 17164361 DOI: 10.1158/1055-9965.Epi-06-0391  0.286
1994 Seeman TE, Berkman LF, Kohout F, Lacroix A, Glynn R, Blazer D. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Annals of Epidemiology. 3: 325-35. PMID 8275207 DOI: 10.1016/1047-2797(93)90058-C  0.285
2007 Albert MA, Glynn RJ, Buring JE, Ridker PM. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. The American Journal of Cardiology. 99: 1246-51. PMID 17478152 DOI: 10.1016/J.Amjcard.2006.12.041  0.285
2012 Jimenez M, Chiuve SE, Glynn RJ, Stampfer MJ, Camargo CA, Willett WC, Manson JE, Rexrode KM. Alcohol consumption and risk of stroke in women. Stroke; a Journal of Cerebral Circulation. 43: 939-45. PMID 22403048 DOI: 10.1161/Strokeaha.111.639435  0.285
2015 Franklin JM, Eddings W, Glynn RJ, Schneeweiss S. Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses. American Journal of Epidemiology. 182: 651-9. PMID 26233956 DOI: 10.1093/Aje/Kwv108  0.285
2012 Mora S, Glynn RJ, Boekholdt SM, Nordestgaard BG, Kastelein JJ, Ridker PM. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). Journal of the American College of Cardiology. 59: 1521-8. PMID 22516441 DOI: 10.1016/J.Jacc.2011.12.035  0.284
2014 Wang L, Sesso HD, Glynn RJ, Christen WG, Bubes V, Manson JE, Buring JE, Gaziano JM. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial. The American Journal of Clinical Nutrition. 100: 915-23. PMID 25008853 DOI: 10.3945/Ajcn.114.085480  0.284
2009 Glynn RJ, MacFadyen JG, Ridker PM. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. Clinical Chemistry. 55: 305-12. PMID 19095726 DOI: 10.1373/Clinchem.2008.120642  0.284
1995 Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet (London, England). 345: 825-9. PMID 7898229 DOI: 10.1016/S0140-6736(95)92964-9  0.284
2008 Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. American Heart Journal. 156: 1103-9. PMID 19033005 DOI: 10.1016/J.Ahj.2008.07.027  0.284
2009 Everett BM, Glynn RJ, Buring JE, Ridker PM. Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women. Journal of Thrombosis and Haemostasis : Jth. 7: 588-96. PMID 19187075 DOI: 10.1111/J.1538-7836.2009.03302.X  0.284
2017 Krumme AA, Pawar A, Schneeweiss S, Glynn RJ, Choudhry NK, Kulldorff M, Ortiz AS, Avorn J, Gagne JJ. Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study. Journal of Comparative Effectiveness Research. PMID 29264930 DOI: 10.2217/Cer-2017-0053  0.284
1994 Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clinical Pharmacology and Therapeutics. 55: 76-83. PMID 7905370 DOI: 10.1038/Clpt.1994.13  0.283
2009 Christen WG, Glynn RJ, Chew EY, Buring JE. Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology. 116: 2386-92. PMID 19815293 DOI: 10.1016/J.Ophtha.2009.05.031  0.283
2009 Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (Cambridge, Mass.). 20: 512-22. PMID 19487948 DOI: 10.1097/Ede.0B013E3181A663Cc  0.283
2018 Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Huybrechts KF. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. Bmj (Clinical Research Ed.). 360: k1218. PMID 29592958 DOI: 10.1136/Bmj.K1218  0.283
1993 Salive ME, Guralnik JM, Glynn RJ. Left-handedness and mortality. American Journal of Public Health. 83: 265-7. PMID 8427338 DOI: 10.2105/Ajph.83.2.265  0.283
1993 Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH. Low-dose aspirin and incidence of colorectal tumors in a randomized trial. Journal of the National Cancer Institute. 85: 1220-4. PMID 8331682 DOI: 10.1093/Jnci/85.15.1220  0.282
1999 Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. High levels of plasma C-reactive protein and future risk of age-related cataract. Annals of Epidemiology. 9: 166-71. PMID 10192648 DOI: 10.1016/S1047-2797(98)00049-0  0.282
2011 Choudhry NK, Patrick AR, Glynn RJ, Avorn J. The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels. Journal of the American College of Cardiology. 57: 784-91. PMID 21310313 DOI: 10.1016/J.Jacc.2010.07.059  0.282
2009 Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. Journal of Clinical Epidemiology. 62: 1226-32. PMID 19356901 DOI: 10.1016/J.Jclinepi.2008.12.005  0.282
2020 Sparks JA, Dellaripa PF, Glynn RJ, Paynter NP, Xu C, Ridker PM, Solomon DH. Pulmonary adverse events of low-dose methotrexate in the randomized double-blind placebo-controlled Card. Arthritis & Rheumatology (Hoboken, N.J.). PMID 32741143 DOI: 10.1002/Art.41452  0.282
1985 Glynn RJ, Bouchard GR, LoCastro JS, Laird NM. Aging and generational effects on drinking behaviors in men: Results from the normative aging study American Journal of Public Health. 75: 1413-1419. PMID 4061714 DOI: 10.2105/Ajph.75.12.1413  0.282
2014 Mora S, Glynn RJ, Ridker PM. Response to letter regarding article, "High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy". Circulation. 129: e481. PMID 24778127 DOI: 10.1161/Circulationaha.114.009345  0.282
2020 Dolan C, Glynn R, Lawlor B. A Systematic Review and Delphi Study to Ascertain Common Risk Factors for Type 2 Diabetes Mellitus and Dementia and Brain-Related Complications of Diabetes in Adults. Canadian Journal of Diabetes. PMID 32127297 DOI: 10.1016/J.Jcjd.2020.01.004  0.281
2012 Schneeweiss S, Rassen JA, Glynn RJ, Myers J, Daniel GW, Singer J, Solomon DH, Kim S, Rothman KJ, Liu J, Avorn J. Supplementing claims data with outpatient laboratory test results to improve confounding adjustment in effectiveness studies of lipid-lowering treatments. Bmc Medical Research Methodology. 12: 180. PMID 23181419 DOI: 10.1186/1471-2288-12-180  0.281
1993 Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Annals of Internal Medicine. 118: 273-8. PMID 8420444 DOI: 10.7326/0003-4819-118-4-199302150-00005  0.281
2009 Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. Jama. 301: 52-62. PMID 19066368 DOI: 10.1001/Jama.2008.862  0.281
1984 Ekerdt DJ, Sparrow D, Glynn RJ, Bossé R. Change in blood pressure and total cholesterol with retirement American Journal of Epidemiology. 120: 64-71. PMID 6741924 DOI: 10.1093/Oxfordjournals.Aje.A113875  0.281
2003 Demissie S, LaValley MP, Horton NJ, Glynn RJ, Cupples LA. Bias due to missing exposure data using complete-case analysis in the proportional hazards regression model. Statistics in Medicine. 22: 545-57. PMID 12590413 DOI: 10.1002/Sim.1340  0.281
2019 Wang SV, Rogers JR, Jin Y, DeiCicchi D, Dejene S, Connors JM, Bates DW, Glynn RJ, Fischer MA. Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation. Bmj Quality & Safety. PMID 31243156 DOI: 10.1136/Bmjqs-2019-009367  0.281
2010 Solomon DH, Rassen JA, Glynn RJ, Garneau K, Levin R, Lee J, Schneeweiss S. The comparative safety of opioids for nonmalignant pain in older adults. Archives of Internal Medicine. 170: 1979-86. PMID 21149754 DOI: 10.1001/Archinternmed.2010.450  0.28
2001 Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM. Analgesic use and renal function in men. Jama. 286: 315-21. PMID 11466097 DOI: 10.1001/Jama.286.3.315  0.28
1997 Camargo CA, Stampfer MJ, Glynn RJ, Grodstein F, Gaziano JM, Manson JE, Buring JE, Hennekens CH. Moderate alcohol consumption and risk for angina pectoris or myocardial infarction in U.S. male physicians. Annals of Internal Medicine. 126: 372-5. PMID 9054281 DOI: 10.7326/0003-4819-126-5-199703010-00005  0.28
1995 Kalish SC, Bohn RL, Mogun H, Glynn RJ, Gurwitz JH, Avorn J. Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. Journal of the American Geriatrics Society. 43: 967-73. PMID 7657936 DOI: 10.1111/J.1532-5415.1995.Tb05559.X  0.28
2013 Mora S, Glynn R, Ridker P. HDL cholesterol, size, particle number, and residual vascular risk after potent statin therapy: the JUPITER trial European Heart Journal. 34: 832-832. DOI: 10.1093/Eurheartj/Eht308.832  0.28
2004 Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation. 109: 2068-73. PMID 15096449 DOI: 10.1161/01.Cir.0000127578.21885.3E  0.28
2009 Flint AJ, Hu FB, Glynn RJ, Jensen MK, Franz M, Sampson L, Rimm EB. Whole grains and incident hypertension in men. The American Journal of Clinical Nutrition. 90: 493-8. PMID 19571218 DOI: 10.3945/Ajcn.2009.27460  0.28
1998 Stürmer T, Glynn RJ, Lee IM, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Annals of Internal Medicine. 128: 713-20. PMID 9556464 DOI: 10.7326/0003-4819-128-9-199805010-00003  0.28
2018 de Boer IH, Zelnick LR, Lin J, Schaumberg D, Wang L, Ruzinski J, Friedenberg G, Duszlak J, Bubes VY, Hoofnagle AN, Thadhani R, Glynn RJ, Buring JE, Sesso H, Manson JE. Vitamin D and OmegA-3 TriaL to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics. Contemporary Clinical Trials. PMID 30282055 DOI: 10.1016/J.Cct.2018.09.014  0.279
2018 Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, ... ... Glynn RJ, et al. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. The New England Journal of Medicine. PMID 30415610 DOI: 10.1056/Nejmoa1809798  0.279
2011 Schneeweiss S, Gagne JJ, Glynn RJ, Ruhl M, Rassen JA. Assessing the comparative effectiveness of newly marketed medications: Methodological challenges and implications for drug development Clinical Pharmacology and Therapeutics. 90: 777-790. PMID 22048230 DOI: 10.1038/Clpt.2011.235  0.279
2006 Stürmer T, Rothman KJ, Glynn RJ. Insights into different results from different causal contrasts in the presence of effect-measure modification Pharmacoepidemiology and Drug Safety. 15: 698-709. PMID 16528796 DOI: 10.1002/Pds.1231  0.278
1999 Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline Journal of the American Medical Association. 281: 438-445. PMID 9952204 DOI: 10.1001/Jama.281.5.438  0.278
2007 Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology. 115: 822-829.e1. PMID 18067963 DOI: 10.1016/J.Ophtha.2007.06.040  0.278
2013 Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 128: 1189-97. PMID 24002795 DOI: 10.1161/Circulationaha.113.002671  0.278
2008 Christen WG, Liu S, Glynn RJ, Gaziano JM, Buring JE. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Archives of Ophthalmology (Chicago, Ill. : 1960). 126: 102-9. PMID 18195226 DOI: 10.1001/Archopht.126.1.102  0.277
1988 Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Survey of Ophthalmology. 32: 239-51. PMID 3279559 DOI: 10.1016/0039-6257(88)90173-7  0.277
2005 Glynn RJ, Rosner B. Multiple imputation to estimate the association between eyes in disease progression with interval-censored data. Statistics in Medicine. 23: 3307-18. PMID 15493063 DOI: 10.1002/Sim.1770  0.277
2007 Albert MA, Glynn RJ, Buring JE, Ridker PM. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 197: 297-302. PMID 17640650 DOI: 10.1016/J.Atherosclerosis.2007.04.051  0.277
2018 Patorno E, Goldfine AB, Schneeweiss S, Everett BM, Glynn RJ, Liu J, Kim SC. Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study. Bmj (Clinical Research Ed.). 360: k119. PMID 29437648 DOI: 10.1136/Bmj.K119  0.277
2000 Rao RS, Glynn RJ, Werler MM, Van Bennekom CM, Mitchell AA. Comparison of alternative survey methods for sensitive self-reported behaviours in a follow-up study of isotretinoin. Journal of Epidemiology and Biostatistics. 5: 133-6. PMID 10890285  0.277
2005 Glynn RJ, Rosner B, Christen WG. 293: Methods for Competing Risks with Frequently Tied Event Times American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S74  0.277
2017 Lawler PR, Akinkuolie AO, Chu AY, Shah SH, Kraus WE, Craig D, Padmanabhan L, Glynn RJ, Ridker PM, Chasman DI, Mora S. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol. Journal of the American Heart Association. 6. PMID 28733430 DOI: 10.1161/Jaha.117.005549  0.276
1996 Christen WG, Glynn RJ, Hennekens CH. Antioxidants and age-related eye disease. Current and future perspectives. Annals of Epidemiology. 6: 60-6. PMID 8680627 DOI: 10.1016/1047-2797(95)00094-1  0.276
2009 Glynn R. Methodological issues affecting estimates of bleeding risks and consequences after venous thromboembolism Thrombosis and Haemostasis. 101: 797-798. DOI: 10.1160/Th09-03-0175  0.276
1989 Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology. 96: 104-8. PMID 2919041 DOI: 10.1016/S0161-6420(89)32936-8  0.276
2011 Brookhart MA, Solomon DH, Glynn RJ, Ridker PM. Effect of rosuvastatin on hemoglobin levels in patients with anemia and low-grade inflammation: a post hoc analysis of the JUPITER trial. Journal of Clinical Pharmacology. 51: 1483-7. PMID 21189308 DOI: 10.1177/0091270010386607  0.276
2014 Choudhry NK, Glynn RJ, Avorn J, Lee JL, Brennan TA, Reisman L, Toscano M, Levin R, Matlin OS, Antman EM, Shrank WH. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. American Heart Journal. 167: 51-58.e5. PMID 24332142 DOI: 10.1016/J.Ahj.2013.09.014  0.276
2018 Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, Glynn RJ, Cohen LS, Mogun H, Huybrechts KF. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes. The American Journal of Psychiatry. appiajp201817040393. PMID 29730938 DOI: 10.1176/Appi.Ajp.2018.17040393  0.276
2018 Kinsey TL, Stürmer T, Poole C, Rothman KJ, Glynn RJ. Changing predictors of statin initiation in US women over two decades. Pharmacoepidemiology and Drug Safety. PMID 30565779 DOI: 10.1002/Pds.4704  0.275
2006 Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, Cook EF, Carney G, Schneeweiss S. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis and Rheumatism. 54: 2757-64. PMID 16947774 DOI: 10.1002/Art.22056  0.275
2019 de Boer IH, Zelnick LR, Ruzinski J, Friedenberg G, Duszlak J, Bubes VY, Hoofnagle AN, Thadhani R, Glynn RJ, Buring JE, Sesso HD, Manson JE. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial. Jama. PMID 31703120 DOI: 10.1001/Jama.2019.17380  0.275
2004 Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). The American Journal of Cardiology. 93: 1238-42. PMID 15135696 DOI: 10.1016/J.Amjcard.2004.01.067  0.275
1996 Turco PD, Connolly J, McCabe P, Glynn RJ. Assessment of functional vision performance: a new test for low vision patients. Ophthalmic Epidemiology. 1: 15-25. PMID 8790609 DOI: 10.3109/09286589409071441  0.275
2017 Glynn RJ, Colditz GA, Tamimi RM, Chen WY, Hankinson SE, Willett WW, Rosner B. Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk. Breast Cancer Research and Treatment. PMID 28589369 DOI: 10.1007/S10549-017-4319-0  0.275
1997 Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. American Journal of Public Health. 86: 1805-8. PMID 9003143 DOI: 10.2105/Ajph.86.12.1805  0.275
2015 Wangge G, Schneeweiss S, Glynn RJ, Gagne JJ. Developing alerting thresholds for prospective drug safety monitoring. Pharmacoepidemiology and Drug Safety. PMID 26596260 DOI: 10.1002/Pds.3905  0.275
2020 Kinsey TL, Stürmer T, Funk MJ, Poole C, Simpson RJ, Glynn RJ. Incidence of venous thromboembolism following initiation of non-steroidal anti-inflammatory drugs in U.S. women. Rheumatology (Oxford, England). PMID 31990357 DOI: 10.1093/Rheumatology/Kez653  0.274
2013 Rosner B, Glynn RJ, Tamimi RM, Chen WY, Colditz GA, Willett WC, Hankinson SE. Breast cancer risk prediction with heterogeneous risk profiles according to breast cancer tumor markers. American Journal of Epidemiology. 178: 296-308. PMID 23645624 DOI: 10.1093/Aje/Kws457  0.274
2013 Mack CD, Glynn RJ, Brookhart MA, Carpenter WR, Meyer AM, Sandler RS, Stürmer T. Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiology and Drug Safety. 22: 810-8. PMID 23296544 DOI: 10.1002/Pds.3386  0.274
2010 Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Stürmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiology and Drug Safety. 19: 1248-55. PMID 20931664 DOI: 10.1002/Pds.2031  0.274
1997 Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Annals of Internal Medicine. 126: 528-31. PMID 9092318 DOI: 10.7326/0003-4819-126-7-199704010-00005  0.273
1995 Gurwitz JH, Field TS, Glynn RJ, Manson JE, Avorn J, Taylor JO, Hennekens CH. Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly. Journal of the American Geriatrics Society. 42: 1235-40. PMID 7983284 DOI: 10.1111/J.1532-5415.1994.Tb06503.X  0.273
2012 Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert MA. Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study. Plos One. 7: e40512. PMID 22815754 DOI: 10.1371/Journal.Pone.0040512  0.273
2009 Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. Journal of the American College of Cardiology. 53: 950-8. PMID 19281925 DOI: 10.1016/J.Jacc.2008.10.060  0.273
2012 Huybrechts KF, Seeger JD, Rothman KJ, Glynn RJ, Avorn J, Schneeweiss S. Bias in comparative effectiveness studies due to regional variation in medical practice intensity: a legitimate concern, or much ado about nothing? Circulation. Cardiovascular Quality and Outcomes. 5: e61-4. PMID 22991351 DOI: 10.1161/Circoutcomes.112.966093  0.273
2016 Khera AV, Demler OV, Adelman SJ, Collins H, Glynn R, Ridker P, Rader D, Mora S. CHOLESTEROL EFFLUX CAPACITY, HDL-PARTICLE NUMBER, AND INCIDENT CARDIOVASCULAR EVENTS: RESULTS FROM THE JUPITER TRIAL Journal of the American College of Cardiology. 67: 1851. DOI: 10.1016/S0735-1097(16)31852-6  0.272
2006 Ridker PM, Danielson E, Rifai N, Glynn RJ. Valsartan, blood pressure reduction, and C-reactive protein: Primary report of the Val-MARC trial Hypertension. 48: 73-79. PMID 16714425 DOI: 10.1161/01.Hyp.0000226046.58883.32  0.272
2009 Shrank WH, Choudhry NK, Solomon DH, Snedden TM, Lee TH, Glynn RJ, Brown TV, Jolda C, Spetman M, Brookhart MA, Schneeweiss S, Avorn J. Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial. American Heart Journal. 157: 613-9. PMID 19332186 DOI: 10.1016/J.Ahj.2008.12.006  0.272
2003 Blake GJ, Pradhan AD, Manson JE, Williams R, Buring J, Ridker PM, Glynn RJ. A prospective study of hemoglobin A1c and future cardiovascular events in women Journal of the American College of Cardiology. 41: 293. DOI: 10.1016/S0735-1097(03)82375-6  0.271
2011 Rassen JA, Solomon DH, Glynn RJ, Schneeweiss S. Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design". Pharmacoepidemiology and Drug Safety. 20: 675-83. PMID 21626604 DOI: 10.1002/Pds.2121  0.271
2020 Adamstein N, MacFadyen J, Rose L, Glynn R, Mehta N, Ridker PM. THE NEUTROPHIL-LYMPHOCYTE RATIO AND ATHEROSCLEROTIC EVENTS: ANALYSES FROM FIVE CONTEMPORARY RANDOMIZED CONTROLLED TRIALS Journal of the American College of Cardiology. 75: 85. DOI: 10.1016/S0735-1097(20)30712-9  0.271
2008 Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England Journal of Medicine. 359: 2195-207. PMID 18997196 DOI: 10.1097/01.Ogx.0000344393.60303.0A  0.271
1990 Glynn RJ, Seddon JM, Gragoudas ES, Egan KM, Hart LJ. Evaluation of tumor regression and other prognostic factors for early and late metastasis after proton irradiation of uveal melanoma. Ophthalmology. 96: 1566-73. PMID 2685710 DOI: 10.1016/S0161-6420(89)32685-6  0.271
2007 Conen D, Ridker PM, Buring JE, Glynn RJ. Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study. Bmj (Clinical Research Ed.). 335: 432. PMID 17704543 DOI: 10.1136/Bmj.39269.672188.Ae  0.271
2010 Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW. Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. American Heart Journal. 160: 139-44. PMID 20598984 DOI: 10.1016/J.Ahj.2010.03.038  0.27
2009 Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. Journal of Clinical Epidemiology. 62: 1233-41. PMID 19345561 DOI: 10.1016/J.Jclinepi.2008.12.006  0.27
2007 Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension (Dallas, Tex. : 1979). 50: 1114-9. PMID 17984371 DOI: 10.1161/Hypertensionaha.107.097634  0.27
2011 Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. Plos One. 6: e27670. PMID 22194788 DOI: 10.1371/Journal.Pone.0027670  0.27
1996 Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, Avorn J. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 51: M74-9. PMID 8612107 DOI: 10.1093/Gerona/51A.2.M74  0.269
2007 Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Circulation. 115: 2128-35. PMID 17420348 DOI: 10.1161/Circulationaha.106.665992  0.269
2000 Glynn RJ, Chae CU, Guralnik JM, Taylor JO, Hennekens CH. Pulse pressure and mortality in older people. Archives of Internal Medicine. 160: 2765-72. PMID 11025786 DOI: 10.1001/Archinte.160.18.2765  0.269
2002 Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology. 21: 123-30. PMID 12006775 DOI: 10.1159/000054809  0.269
2005 Gage BF, Eby CS, Johnson JA, Rieder MJ, Ridker PM, Rettie AE, Aquilante C, Milligan PE, Marsh S, Voora D, Langaee T, Veenstra DL, Birman-Deych E, Glynn R, Nickerson DA, et al. Use of Pharmacogenetics and Clinical Factors To Predict the Maintenance Dose of Warfarin. Blood. 106: 550-550. DOI: 10.1182/Blood.V106.11.550.550  0.268
2004 Solomon DH, Schneeweiss S, Glynn RJ, Levin R, Avorn J. Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important? The American Journal of Medicine. 115: 715-20. PMID 14693324 DOI: 10.1016/J.Amjmed.2003.08.025  0.268
2009 Rosner B, Glynn RJ. Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models. Biometrics. 65: 188-97. PMID 18510654 DOI: 10.1111/J.1541-0420.2008.01062.X  0.268
2010 Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Response to Letter Regarding Article, “Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women” Circulation. 121. DOI: 10.1161/Circulationaha.109.896639  0.268
2020 Christen WG, Darke AK, Gaziano JM, Glynn RJ, Goodman PJ, Minasian LM, Thompson IM. Age-related macular degeneration in a randomized trial of selenium and vitamin E in men: the Select Eye Endpoints (SEE) study (SWOG S0000B). Acta Ophthalmologica. PMID 32701201 DOI: 10.1111/Aos.14538  0.267
2010 Ridker PM, Glynn RJ. EFFICACY OF ROSUVASTATIN IN PRIMARY PREVENTION ACCORDING TO BASELINE LEVELS OF HSCRP IN THE JUPITER TRIAL Journal of the American College of Cardiology. 55: A53.E508. DOI: 10.1016/S0735-1097(10)60509-8  0.267
2013 Kulik A, Desai NR, Shrank WH, Antman EM, Glynn RJ, Levin R, Reisman L, Brennan T, Choudhry NK. Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial. Circulation. 128: S219-25. PMID 24030410 DOI: 10.1161/Circulationaha.112.000337  0.267
2004 Glynn RJ, Rosner B. Methods to evaluate risks for composite end points and their individual components. Journal of Clinical Epidemiology. 57: 113-22. PMID 15125620 DOI: 10.1016/J.Jclinepi.2003.02.001  0.267
2013 Everett BM, Pradhan AD, Solomon DH, Paynter N, Macfadyen J, Zaharris E, Gupta M, Clearfield M, Libby P, Hasan AA, Glynn RJ, Ridker PM. Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. American Heart Journal. 166: 199-207.e15. PMID 23895801 DOI: 10.1016/J.Ahj.2013.03.018  0.267
2001 Morris MC, Scherr PA, Hebert LE, Glynn RJ, Bennett DA, Evans DA. Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study. Archives of Neurology. 58: 1640-6. PMID 11594923 DOI: 10.1001/Archneur.58.10.1640  0.267
2009 Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 119: 2146-52. PMID 19364977 DOI: 10.1161/Circulationaha.108.830042  0.267
1992 Glynn RJ. Falls in Elderly Patients With Glaucoma-Reply Archives of Ophthalmology. 110: 169. DOI: 10.1001/Archopht.1992.01080140019006  0.267
2011 Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Joffe MM, Glynn RJ. Effects of adjusting for instrumental variables on bias and precision of effect estimates. American Journal of Epidemiology. 174: 1213-22. PMID 22025356 DOI: 10.1093/Aje/Kwr364  0.267
2002 Solomon DH, Glynn RJ, Avorn J. Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet (London, England). 360: 90. PMID 12114070 DOI: 10.1016/S0140-6736(02)09350-9  0.267
2010 Conen D, Chae CU, Guralnik JM, Glynn RJ. Influence of blood pressure and blood pressure change on the risk of congestive heart failure in the elderly. Swiss Medical Weekly. 140: 202-208. DOI: 10.4414/Smw.2010.12780  0.267
2006 Sesso HD, Gaziano JM, Glynn RJ, Buring JE. Value of an Endpoints Committee versus the use of nosologists for validating cause of death. Contemporary Clinical Trials. 27: 333-9. PMID 16387554 DOI: 10.1016/J.Cct.2005.11.007  0.267
2002 Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ. Nephrologist care and mortality in patients with chronic renal insufficiency. Archives of Internal Medicine. 162: 2002-6. PMID 12230424 DOI: 10.1001/Archinte.162.17.2002  0.266
2005 Schneeweiss S, Glynn RJ, Avorn J, Solomon DH. A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitors. Journal of Clinical Epidemiology. 58: 98-102. PMID 15649677 DOI: 10.1016/J.Jclinepi.2004.06.002  0.266
2006 Glynn RJ, Schneeweiss S, Wang PS, Levin R, Avorn J. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. Journal of Clinical Epidemiology. 59: 819-28. PMID 16828675 DOI: 10.1016/J.Jclinepi.2005.12.012  0.266
2020 Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, Levin R, Evers T, Wang SV, Desai RJ. Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model. Clinical Epidemiology. 12: 607-616. PMID 32606986 DOI: 10.2147/Clep.S253612  0.266
2001 Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, Manson JE, Hennekens CH. Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. Archives of Ophthalmology (Chicago, Ill. : 1960). 119: 1143-9. PMID 11483080 DOI: 10.1001/Archopht.119.8.1143  0.266
2000 Bohn RL, Gurwitz JH, Yeomans SM, Glynn RJ, Pasquale LR, Walker AM, Avorn J. Which patients are treated for glaucoma? An observational analysis. Journal of Glaucoma. 9: 38-44. PMID 10708230 DOI: 10.1097/00061198-200002000-00008  0.265
2019 Franklin JM, Glynn RJ, Martin D, Schneeweiss S. Evaluating the Use of Nonrandomized Real World Data Analyses for Regulatory Decision Making. Clinical Pharmacology and Therapeutics. PMID 30636285 DOI: 10.1002/Cpt.1351  0.265
2002 Avorn J, Winkelmayer WC, Bohn RL, Levin R, Glynn RJ, Levy E, Owen W. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. Journal of Clinical Epidemiology. 55: 711-6. PMID 12160919 DOI: 10.1016/S0895-4356(02)00415-8  0.265
2017 Lawler PR, Akinkuolie AO, Ridker PM, Sniderman AD, Buring JE, Glynn RJ, Chasman DI, Mora S. Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women. Clinical Chemistry. PMID 28174174 DOI: 10.1373/Clinchem.2016.264515  0.265
2018 Wang SV, Huybrechts KF, Fischer MA, Franklin JM, Glynn RJ, Schneeweiss S, Gagne JJ. Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiology and Drug Safety. PMID 29383858 DOI: 10.1002/Pds.4395  0.265
2006 Stürmer T, Buring JE, Lee IM, Kurth T, Gaziano JM, Glynn RJ. Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. The American Journal of Medicine. 119: 494-502. PMID 16750963 DOI: 10.1016/J.Amjmed.2005.11.011  0.264
2018 Conover MM, Stürmer T, Poole C, Glynn RJ, Simpson RJ, Pate V, Jonsson Funk M. Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches. Pharmacoepidemiology and Drug Safety. PMID 29655187 DOI: 10.1002/Pds.4435  0.264
2016 Schneeweiss S, Eddings W, Glynn RJ, Patorno E, Rassen J, Franklin JM. Variable selection for confounding adjustment in high-dimensional covariate spaces when analyzing healthcare databases. Epidemiology (Cambridge, Mass.). PMID 27779497 DOI: 10.1097/Ede.0000000000000581  0.264
2013 Cheung WY, Schaefer K, May CW, Glynn RJ, Curtis LH, Stevenson LW, Setoguchi S. Enrollment and events of hospice patients with heart failure vs. cancer. Journal of Pain and Symptom Management. 45: 552-60. PMID 22940560 DOI: 10.1016/J.Jpainsymman.2012.03.006  0.264
2016 Lauffenburger JC, Shrank WH, Bitton A, Franklin JM, Glynn RJ, Krumme AA, Matlin OS, Pezalla EJ, Spettell CM, Brill G, Choudhry NK. Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study. Annals of Internal Medicine. PMID 27842386 DOI: 10.7326/M15-2659  0.264
2000 Cronin-Stubbs D, Mendes De Leon CF, Beckett LA, Field TS, Glynn RJ, Evans DA. Six-year effect of depressive symptoms on the course of physical disability in community-living older adults Archives of Internal Medicine. 160: 3074-3080. PMID 11074736 DOI: 10.1001/Archinte.160.20.3074  0.264
2013 Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M, Sesso HD. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Annals of Internal Medicine. 159: 806-14. PMID 24490265 DOI: 10.7326/0003-4819-159-12-201312170-00006  0.264
1988 Campion EW, deLabry LO, Glynn RJ. The effect of age on serum albumin in healthy males: report from the Normative Aging Study. Journal of Gerontology. 43: M18-20. PMID 3335748 DOI: 10.1093/Geronj/43.1.M18  0.264
2013 Rassen JA, Shelat AA, Franklin JM, Glynn RJ, Solomon DH, Schneeweiss S. Matching by propensity score in cohort studies with three treatment groups. Epidemiology (Cambridge, Mass.). 24: 401-9. PMID 23532053 DOI: 10.1097/Ede.0B013E318289Dedf  0.264
2014 Everett BM, Mora S, Glynn RJ, MacFadyen J, Ridker PM. Safety profile of subjects treated to very low low-density lipoprotein cholesterol levels (<30 mg/dl) with rosuvastatin 20 mg daily (from JUPITER). The American Journal of Cardiology. 114: 1682-9. PMID 25439449 DOI: 10.1016/J.Amjcard.2014.08.041  0.264
1989 Egan KM, Gragoudas ES, Seddon JM, Glynn RJ, Munzenreider JE, Goitein M, Verhey L, Urie M, Koehler A. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 96: 1377-82; discussion . PMID 2550868 DOI: 10.1016/S0161-6420(89)32738-2  0.263
2000 Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Buring JE, Hennekens CH, Manson JE. Smoking cessation and risk of age-related cataract in men. Jama. 284: 713-6. PMID 10927779 DOI: 10.1001/Jama.284.6.713  0.263
2010 Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA. Burden of smoking on cause-specific mortality: application to the Nurses' Health Study. Tobacco Control. 19: 248-54. PMID 20501499 DOI: 10.1136/Tc.2009.032839  0.263
2002 Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R, Avorn J. Dopamine antagonists and the development of breast cancer. Archives of General Psychiatry. 59: 1147-54. PMID 12470131 DOI: 10.1001/Archpsyc.59.12.1147  0.263
2002 Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. Jama. 288: 455-61. PMID 12132975 DOI: 10.1001/Jama.288.4.455  0.263
2017 Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 29244057 DOI: 10.1093/Gerona/Glx229  0.263
2019 Eberly LA, Richterman A, Beckett AG, Wispelwey B, Marsh RH, Cleveland Manchanda EC, Chang CY, Glynn RJ, Brooks KC, Boxer R, Kakoza R, Goldsmith J, Loscalzo J, Morse M, Lewis EF, et al. Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center. Circulation. Heart Failure. 12: e006214. PMID 31658831 DOI: 10.1161/Circheartfailure.119.006214  0.263
2010 Ridker PM, Glynn RJ. EFFICACY OF ROSUVASTATIN AMONG MEN AND WOMEN WITH CHRONIC KIDNEY DISEASE AND ELEVATED HSCRP: THE JUPITER TRIAL Journal of the American College of Cardiology. 55: A54.E509. DOI: 10.1016/S0735-1097(10)60510-4  0.262
2009 Zee RY, Bubes V, Shrivastava S, Ridker PM, Glynn RJ. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. Clinica Chimica Acta; International Journal of Clinical Chemistry. 402: 189-92. PMID 19263529 DOI: 10.1016/J.Cca.2009.01.011  0.262
1999 Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) American Heart Journal. 138: 849-55. PMID 10539815 DOI: 10.1016/S0002-8703(99)70009-8  0.262
1999 Ajani UA, Christen WG, Manson JE, Glynn RJ, Schaumberg D, Buring JE, Hennekens CH. A prospective study of alcohol consumption and the risk of age-related macular degeneration. Annals of Epidemiology. 9: 172-7. PMID 10192649 DOI: 10.1016/S1047-2797(98)00053-2  0.262
2008 Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, ... ... Glynn RJ, et al. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clinical Pharmacology and Therapeutics. 84: 326-31. PMID 18305455 DOI: 10.1038/Clpt.2008.10  0.262
2008 Conen D, Everett BM, Glynn RJ, Ridker PM. Effect of valsartan compared with valsartan/hydrochlorothiazide on plasma levels of cellular adhesion molecules: the Val-MARC trial. Heart (British Cardiac Society). 94: e13. PMID 17923463 DOI: 10.1136/Hrt.2007.126169  0.262
2020 Connolly JG, Glynn RJ, Schneeweiss S, Gagne JJ. Improving measurement of binary covariates in claims data: A simulation study. Pharmacoepidemiology and Drug Safety. PMID 31972062 DOI: 10.1002/Pds.4961  0.262
2019 Bykov K, Schneeweiss S, Glynn RJ, Mittleman MA, Gagne JJ. A case-crossover-based screening approach to identifying clinically relevant drug-drug interactions in electronic healthcare data. Clinical Pharmacology and Therapeutics. PMID 30663781 DOI: 10.1002/Cpt.1376  0.261
2015 Margulis AV, Mittleman MA, Glynn RJ, Holmes LB, Hernández-Díaz S. Effects of gestational age at enrollment in pregnancy exposure registries. Pharmacoepidemiology and Drug Safety. 24: 343-52. PMID 25702683 DOI: 10.1002/Pds.3731  0.261
2019 Franklin JM, Pawar A, Martin D, Glynn RJ, Levenson M, Temple R, Schneeweiss S. Nonrandomized real-world evidence to support regulatory decision-making: Process for a randomized trial replication project. Clinical Pharmacology and Therapeutics. PMID 31541454 DOI: 10.1002/Cpt.1633  0.261
2004 Schneeweiss S, Wang PS, Avorn J, Maclure M, Levin R, Glynn RJ. Consistency of performance ranking of comorbidity adjustment scores in Canadian and U.S. utilization data. Journal of General Internal Medicine. 19: 444-50. PMID 15109342 DOI: 10.1111/J.1525-1497.2004.30109.X  0.261
2012 Margulis AV, Mitchell AA, Gilboa SM, Werler MM, Mittleman MA, Glynn RJ, Hernandez-Diaz S. Use of topiramate in pregnancy and risk of oral clefts. American Journal of Obstetrics and Gynecology. 207: 405.e1-7. PMID 22917484 DOI: 10.1016/J.Ajog.2012.07.008  0.261
2003 Parr KG, Patel MA, Dekker R, Levin R, Glynn R, Avorn J, Morse DS. Multivariate predictors of blood product use in cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 17: 176-81. PMID 12698398 DOI: 10.1053/Jcan.2003.44  0.26
1997 Camargo CA, Stampfer MJ, Glynn RJ. Moderate Alcohol Use Reduces the Risk of Anginal and Myocardial Infarction The Nurse Practitioner. 22: 160. DOI: 10.1097/00006205-199706000-00015  0.26
2001 Winkelmayer WC, Glynn RJ, Levin R, Owen W, Avorn J. Late referral and modality choice in end-stage renal disease Kidney International. 60: 1547-1554. PMID 11576371 DOI: 10.1046/J.1523-1755.2001.00958.X  0.26
1988 Glynn RJ, de Labry LO, Hou DM. Alcohol consumption, type A behavior, and demographic variables. Results from the Normative Aging Study. American Journal of Epidemiology. 127: 310-20. PMID 3337085 DOI: 10.1093/Oxfordjournals.Aje.A114806  0.26
2015 Mack CD, Brookhart MA, Glynn RJ, Meyer AM, Carpenter WR, Sandler RS, Stürmer T. Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. Epidemiology (Cambridge, Mass.). 26: 690-9. PMID 26196683 DOI: 10.1097/Ede.0000000000000355  0.26
2012 Gagne JJ, Walker AM, Glynn RJ, Rassen JA, Schneeweiss S. An event-based approach for comparing the performance of methods for prospective medical product monitoring. Pharmacoepidemiology and Drug Safety. 21: 631-9. PMID 22223544 DOI: 10.1002/Pds.2347  0.26
2000 Glynn RJ, Rosner B. Methods to quantify the relation between disease progression in paired eyes. American Journal of Epidemiology. 151: 965-74. PMID 10853635 DOI: 10.1093/Oxfordjournals.Aje.A010140  0.26
2006 Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. Journal of Thrombosis and Haemostasis : Jth. 4: 1208-14. PMID 16706961 DOI: 10.1111/J.1538-7836.2006.01935.X  0.259
2013 Patrick AR, Franklin JM, Weinstein MC, Glynn RJ, Schneeweiss S. Sequential value-of-information assessment for prospective drug safety monitoring using claims databases: the comparative safety of prasugrel v. clopidogrel. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 949-60. PMID 23920434 DOI: 10.1177/0272989X13497997  0.259
2013 Danik JS, Buring JE, Chasman DI, Zee RYL, Ridker PM, Glynn RJ. Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21483 women Journal of Thrombosis and Haemostasis. 11: 205-208. PMID 23137279 DOI: 10.1111/Jth.12056  0.259
2007 Huang PY, Buring JE, Ridker PM, Glynn RJ. Awareness, accuracy, and predictive validity of self-reported cholesterol in women. Journal of General Internal Medicine. 22: 606-13. PMID 17370032 DOI: 10.1007/S11606-007-0144-1  0.259
2016 Jiménez MC, Rexrode KM, Kotler G, Everett BM, Glynn RJ, Lee IM, Buring JE, Ridker PM, Sesso HD. Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women. American Journal of Hypertension. PMID 27235695 DOI: 10.1093/Ajh/Hpw050  0.259
1995 Monane M, Gurwitz JH, Lipsitz LA, Glynn RJ, Choodnovskiy I, Avorn J. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. Journal of the American Geriatrics Society. 43: 618-22. PMID 7775718 DOI: 10.1111/J.1532-5415.1995.Tb07194.X  0.259
2012 Polinski JM, Brookhart MA, Glynn RJ, Schneeweiss S. Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance. Journal of Clinical Psychopharmacology. 32: 3-10. PMID 22198455 DOI: 10.1097/Jcp.0B013E31823Fb5C4  0.258
2011 Li Q, Glynn RJ, Dreyer NA, Liu J, Mogun H, Setoguchi S. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients. Pharmacoepidemiology and Drug Safety. 20: 700-8. PMID 21608070 DOI: 10.1002/Pds.2146  0.258
2020 Franklin JM, Glynn RJ, Suissa S, Schneeweiss S. Emulation Differences vs. Biases When Calibrating Real-World Evidence Findings Against Randomized Controlled Trials. Clinical Pharmacology and Therapeutics. PMID 32052415 DOI: 10.1002/Cpt.1793  0.258
1998 Grodstein F, Martinez E, EA P, Sturmer T, Glynn RJ, IM L, Hoover RN. Colorectal Cancer Risk Factors The Nurse Practitioner. 23: 90???95. DOI: 10.1097/00006205-199807000-00009  0.258
1993 Shingleton BJ, Richter CU, Dharma SK, Tong L, Bellows AR, Hutchinson BT, Glynn RJ. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology. 100: 1324-9. PMID 8371919 DOI: 10.1016/S0161-6420(93)31480-6  0.258
1999 O'Donnell CJ, Glynn RJ, Field TS, Averback R, Satterfield S, Friesenger GC, Taylor JO, Hennekens CH. Misclassification and under-reporting of acute myocardial infarction by elderly persons: implications for community-based observational studies and clinical trials. Journal of Clinical Epidemiology. 52: 745-51. PMID 10465319 DOI: 10.1016/S0895-4356(99)00054-2  0.258
1989 Poggio EC, Glynn RJ, Schein OD, Seddon JM, Shannon MJ, Scardino VA, Kenyon KR. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. The New England Journal of Medicine. 321: 779-83. PMID 2770809 DOI: 10.1056/Nejm198909213211202  0.258
2005 Hudson JI, Pope HG, Glynn RJ. The cross-sectional cohort study: an underutilized design. Epidemiology (Cambridge, Mass.). 16: 355-9. PMID 15824552 DOI: 10.1097/01.Ede.0000158224.50593.E3  0.258
2007 Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. European Heart Journal. 28: 2937-43. PMID 17925342 DOI: 10.1093/Eurheartj/Ehm400  0.258
1983 Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961--1980. Arthritis and Rheumatism. 26: 87-93. PMID 6824508 DOI: 10.1002/Art.1780260115  0.258
2013 Djoussé L, Wilk JB, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM. Association between adiponectin and heart failure risk in the physicians' health study. Obesity (Silver Spring, Md.). 21: 831-4. PMID 23712986 DOI: 10.1002/Oby.20260  0.258
2017 Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet (London, England). PMID 28855077 DOI: 10.1016/S0140-6736(17)32247-X  0.257
2016 Patorno E, Everett BM, Goldfine AB, Glynn RJ, Liu J, Gopalakrishnan C, Kim SC. Comparative Cardiovascular Safety of Glucagon-Like Peptide-1 Receptor Agonists versus Other Antidiabetic Drugs in Routine Care: a Cohort Study. Diabetes, Obesity & Metabolism. PMID 27003762 DOI: 10.1111/Dom.12665  0.257
2007 Glynn RJ, Brookhart MA, Stedman M, Avorn J, Solomon DH. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Medical Care. 45: S38-43. PMID 17909381 DOI: 10.1097/Mlr.0B013E318070C0A0  0.256
2006 Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models American Journal of Epidemiology. 163: 1149-1156. PMID 16624967 DOI: 10.1093/Aje/Kwj149  0.256
2002 Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. Journal of the American Geriatrics Society. 49: 1685-90. PMID 11844004 DOI: 10.1111/J.1532-5415.2001.49280.X  0.255
2004 Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Archives of Internal Medicine. 164: 1567-72. PMID 15277291 DOI: 10.1001/Archinte.164.14.1567  0.254
2005 Christen W, Glynn R, Sperduto R, Chew E, Buring J. Age-related cataract in a randomized trial of beta-carotene in women. Ophthalmic Epidemiology. 11: 401-12. PMID 15590586 DOI: 10.1080/09286580490515152  0.254
2002 Sesso H, Chen R, L’Italien G, Lapuerta P, Lee W, Paramore C, Glynn R. Pcv10 Blood Pressure Reduction And Gains In Life Expectancy Based Upon A Markov Model Of Primary And Secondary Cardiovascular Events Value in Health. 5: 164-165. DOI: 10.1016/S1098-3015(10)60924-2  0.254
2020 Lin KJ, Rosenthal GE, Murphy SN, Mandl KD, Jin Y, Glynn RJ, Schneeweiss S. External Validation of an Algorithm to Identify Patients with High Data-Completeness in Electronic Health Records for Comparative Effectiveness Research. Clinical Epidemiology. 12: 133-141. PMID 32099479 DOI: 10.2147/Clep.S232540  0.254
2003 Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 107: 443-7. PMID 12551869 DOI: 10.1161/01.Cir.0000045669.16499.Ec  0.254
2009 Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. European Heart Journal. 30: 1378-84. PMID 19297384 DOI: 10.1093/Eurheartj/Ehp072  0.254
2012 Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik D, Stein CM, ... ... Glynn RJ, et al. Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thrombosis and Haemostasis. 107: 232-40. PMID 22186998 DOI: 10.1160/Th11-06-0388  0.254
1993 Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma: adherence by the elderly. American Journal of Public Health. 83: 711-6. PMID 8484454 DOI: 10.2105/Ajph.83.5.711  0.254
1992 Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Archives of Ophthalmology (Chicago, Ill. : 1960). 110: 475-9. PMID 1562251 DOI: 10.1001/Archopht.1992.01080160053029  0.254
2003 Christen WG, Manson JE, Glynn RJ, Gaziano JM, Sperduto RD, Buring JE, Hennekens CH. A randomized trial of beta carotene and age-related cataract in US physicians. Archives of Ophthalmology (Chicago, Ill. : 1960). 121: 372-8. PMID 12617708 DOI: 10.1097/00132578-200307000-00013  0.254
2007 Christen WG, Manson JE, Glynn RJ, Gaziano JM, Chew EY, Buring JE, Hennekens CH. Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Archives of Ophthalmology (Chicago, Ill. : 1960). 125: 333-9. PMID 17353403 DOI: 10.1001/Archopht.125.3.333  0.254
2015 Lawler PR, Akinkuolie A, Buring J, Ridker P, Glynn R, Mora S. A NOVEL BIOMARKER OF CIRCULATING GLYCOPROTEINS AND CARDIOVASCULAR AND ALL-CAUSE MORTALITY AMONG 39,521 INITIALLY HEALTHY ADULTS Journal of the American College of Cardiology. 65: A1358. DOI: 10.1016/S0735-1097(15)61358-4  0.254
2004 Schneeweiss S, Maclure M, Carleton B, Glynn RJ, Avorn J. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations. Bmj (Clinical Research Ed.). 328: 560. PMID 14982865 DOI: 10.1136/Bmj.38020.698194.F6  0.253
1993 Glynn RJ, Stukel TA, Sharp SM, Bubolz TA, Freeman JL, Fisher ES. Estimating the variance of standardized rates of recurrent events, with application to hospitalizations among the elderly in New England. American Journal of Epidemiology. 137: 776-86. PMID 8484369 DOI: 10.1093/Oxfordjournals.Aje.A116738  0.253
1992 Glynn RJ, Rosner B. Accounting for the correlation between fellow eyes in regression analysis. Archives of Ophthalmology (Chicago, Ill. : 1960). 110: 381-7. PMID 1543458 DOI: 10.1001/Archopht.1992.01080150079033  0.253
1991 Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 98: 383-9; discussion 39. PMID 2023760 DOI: 10.1016/S0161-6420(91)32285-1  0.253
1987 Gragoudas ES, Seddon JM, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, Goitein M, Verhey L, Urie M, Koehler A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 94: 349-53. PMID 3035451 DOI: 10.1016/S0161-6420(87)33456-6  0.253
1999 Field TS, Gurwitz JH, Glynn RJ, Salive ME, Gaziano JM, Taylor JO, Hennekens CH. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. Journal of the American Geriatrics Society. 47: 507-11. PMID 10323640 DOI: 10.1111/J.1532-5415.1999.Tb02561.X  0.253
2018 Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). European Heart Journal. PMID 30165610 DOI: 10.1093/Eurheartj/Ehy310  0.253
2017 Lin KJ, Singer DE, Glynn RJ, Blackley S, Zhou L, Liu J, Dube G, Oertel LB, Schneeweiss S. Prediction Score for Anticoagulation Control Quality Among Older Adults. Journal of the American Heart Association. 6. PMID 28982676 DOI: 10.1161/Jaha.117.006814  0.253
2017 Glynn RJ. Use of Propensity Scores To Design Observational Comparative Effectiveness Studies. Journal of the National Cancer Institute. 109. PMID 28376196 DOI: 10.1093/Jnci/Djw345  0.252
2004 Wang PS, Benner JS, Glynn RJ, Winkelmayer WC, Mogun H, Avorn J. How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiology and Drug Safety. 13: 11-9. PMID 14971118 DOI: 10.1002/Pds.819  0.252
1997 Pfeffer MA, Greaves SC, Arnold JM, Glynn RJ, LaMotte FS, Lee RT, Menapace FJ, Rapaport E, Ridker PM, Rouleau JL, Solomon SD, Hennekens CH. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 95: 2643-51. PMID 9193433 DOI: 10.1161/01.Cir.95.12.2643  0.252
2001 Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant age-related maculopathy in men. Archives of Ophthalmology (Chicago, Ill. : 1960). 119: 1259-65. PMID 11545630 DOI: 10.1001/Archopht.119.9.1259  0.252
1981 Bossé R, Garvery AJ, Glynn RJ. Age and addiction to smoking. Addictive Behaviors. 5: 341-51. PMID 7211532 DOI: 10.1016/0306-4603(80)90008-8  0.252
1994 Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. Journal of Gerontology. 49: M85-94. PMID 8126356 DOI: 10.1093/Geronj/49.2.M85  0.251
1984 Sparrow D, Glynn RJ, Cohen M, Weiss ST. The relationship of the peripheral leukocyte count and cigarette smoking to pulmonary function among adult men. Chest. 86: 383-6. PMID 6467999 DOI: 10.1378/Chest.86.3.383  0.251
2012 McPhee JT, Ho KJ, Lopez J, Glynn R, Belkin M, Menard MT. RR3. Protamine Sulfate Use Does Not Lower Hemorrhagic Complications in Lower Extremity Bypass (LEB) Journal of Vascular Surgery. 55: 87S. DOI: 10.1016/J.Jvs.2012.03.212  0.251
2009 Ridker PM, Glynn RJ. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial – Authors' reply The Lancet. 374: 26-27. DOI: 10.1016/S0140-6736(09)61234-4  0.251
2000 Morris MC, Scherr PA, Hebert LE, Bennett DA, Wilson RS, Glynn RJ, Evans DA. The cross-sectional association between blood pressure and Alzheimer's disease in a biracial community population of older persons. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 55: M130-6. PMID 10795724 DOI: 10.1093/Gerona/55.3.M130  0.251
2014 Djoussé L, Petrone AB, Weir NL, Hanson NQ, Glynn RJ, Tsai MY, Gaziano JM. Repeated versus single measurement of plasma omega-3 fatty acids and risk of heart failure. European Journal of Nutrition. 53: 1403-8. PMID 24395612 DOI: 10.1007/S00394-013-0642-3  0.251
1999 Pan CX, Glynn RJ, Mogun H, Choodnovskiy I, Avorn J. Definition of race and ethnicity in older people in Medicare and Medicaid. Journal of the American Geriatrics Society. 47: 730-3. PMID 10366176 DOI: 10.1111/J.1532-5415.1999.Tb01599.X  0.251
1995 Stukel TA, Glynn RJ, Fisher ES, Sharp SM, Lu-Yao G, Wennberg JE. Standardized rates of recurrent outcomes. Statistics in Medicine. 13: 1781-91. PMID 7997711 DOI: 10.1002/Sim.4780131709  0.251
2017 Lin KJ, Glynn RJ, Singer DE, Murphy SN, Lii J, Schneeweiss S. Out-of-system care and recording of patient characteristics critical for comparative effectiveness research. Epidemiology (Cambridge, Mass.). PMID 29283893 DOI: 10.1097/Ede.0000000000000794  0.25
2000 Schaumberg DA, Glynn RJ, Christen WG, Hankinson SE, Hennekens CH. Relations of body fat distribution and height with cataract in men. The American Journal of Clinical Nutrition. 72: 1495-502. PMID 11101477 DOI: 10.1093/Ajcn/72.6.1495  0.25
2010 Albert MA, Cozier Y, Ridker PM, Palmer JR, Glynn RJ, Rose L, Halevy N, Rosenberg L. Perceptions of race/ethnic discrimination in relation to mortality among Black women: results from the Black Women's Health Study. Archives of Internal Medicine. 170: 896-904. PMID 20498418 DOI: 10.1001/Archinternmed.2010.116  0.25
1998 Glynn RJ. Concerns About Run-in Periods in Randomized Trials Jama: the Journal of the American Medical Association. 279: 1526-1527. DOI: 10.1001/Jama.279.19.1526  0.249
2001 Solomon SD, Glynn RJ, Greaves S, Ajani U, Rouleau JL, Menapace F, Arnold JM, Hennekens C, Pfeffer MA. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study. Annals of Internal Medicine. 134: 451-8. PMID 11255520 DOI: 10.7326/0003-4819-134-6-200103200-00009  0.249
2013 Conen D, Glynn RJ, Sandhu RK, Tedrow UB, Albert CM. Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. International Journal of Cardiology. 168: 1894-9. PMID 23333369 DOI: 10.1016/J.Ijcard.2012.12.060  0.249
2019 Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Hernández-Díaz S, Glynn RJ. A tool for empirical equipoise assessment in multigroup comparative effectiveness research. Pharmacoepidemiology and Drug Safety. PMID 31131965 DOI: 10.1002/Pds.4767  0.249
2017 Lampson BL, Yu L, Glynn RJ, Barrientos JC, Jacobsen ED, Banerji V, Jones JA, Walewska R, Savage KJ, Michaud GF, Moslehi JJ, Brown JR. Ventricular arrhythmias and sudden death in patients taking ibrutinib. Blood. PMID 28223277 DOI: 10.1182/Blood-2016-10-742437  0.248
1997 Rosner B, Glynn RJ. Multivariate methods for clustered ordinal data with applications to survival analysis. Statistics in Medicine. 16: 357-72. PMID 9044526 DOI: 10.1002/(Sici)1097-0258(19970228)16:4<357::Aid-Sim420>3.0.Co;2-3  0.248
2008 Dormuth CR, Maclure M, Glynn RJ, Neumann P, Brookhart AM, Schneeweiss S. Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications. Clinical Therapeutics. 1038-50. PMID 18640478 DOI: 10.1016/J.Clinthera.2008.06.003  0.248
2005 Brookhart MA, Solomon DH, Wang P, Glynn RJ, Avorn J, Schneeweiss S. Explained variation in a model of therapeutic decision making is partitioned across patient, physician, and clinic factors. Journal of Clinical Epidemiology. 59: 18-25. PMID 16360557 DOI: 10.1016/J.Jclinepi.2005.07.005  0.248
1981 Borkan GA, Glynn RJ, Bachman SS, Bossé R, Weiss ST. Relationship between cigarette smoking, chest size and body size in health-screened adult males. Annals of Human Biology. 8: 153-60. PMID 7247344 DOI: 10.1080/03014468100004891  0.248
2004 Stürmer T, Glynn RJ, Avorn J, Rothman K, Schneeweiss S. P2.63: Controlling Confounding Using Propensity Scores: Increasing Use and Persisting Questions Biometrical Journal. 46: 152-152. DOI: 10.1002/Bimj.200490214  0.248
2018 Everett BM, Cornel J, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM. Anti-Inflammatory Therapy with Canakinumab for the Prevention of Hospitalization for Heart Failure. Circulation. PMID 30586730 DOI: 10.1161/Circulationaha.118.038010  0.248
2017 Engelhart S, Glynn RJ, Schur PH. Disease associations with isolated elevations of each of the four IgG subclasses. Seminars in Arthritis and Rheumatism. PMID 28457528 DOI: 10.1016/J.Semarthrit.2017.03.021  0.248
2007 Grodstein F, Kang JH, Glynn RJ, Cook NR, Gaziano JM. A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Archives of Internal Medicine. 167: 2184-90. PMID 17998490 DOI: 10.1001/Archinte.167.20.2184  0.248
2011 Polinski JM, Shrank WH, Huskamp HA, Glynn RJ, Liberman JN, Schneeweiss S. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap. Plos Medicine. 8: e1001075. PMID 21857811 DOI: 10.1371/Journal.Pmed.1001075  0.247
2006 Schneeweiss S, Maclure M, Dormuth CR, Glynn RJ, Canning C, Avorn J. A therapeutic substitution policy for proton pump inhibitors: clinical and economic consequences. Clinical Pharmacology and Therapeutics. 79: 379-88. PMID 16580906 DOI: 10.1016/J.Clpt.2005.12.304  0.247
1988 Shingleton BJ, Richter CU, Bellows AR, Hutchinson BT, Glynn RJ. Long-term efficacy of argon laser trabeculoplasty. Ophthalmology. 94: 1513-8. PMID 3431820 DOI: 10.1016/S0161-6420(87)33253-1  0.247
2003 Duetz MS, Schneeweiss S, Maclure M, Abel T, Glynn RJ, Soumerai SB. Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia. Clinical Therapeutics. 25: 273-84. PMID 12637126 DOI: 10.1016/S0149-2918(03)90037-3  0.247
2002 Winkelmayer WC, Owen W, Glynn RJ, Levin R, Avorn J. Preventive health care measures before and after start of renal replacement therapy. Journal of General Internal Medicine. 17: 588-95. PMID 12213139 DOI: 10.1046/J.1525-1497.2002.11021.X  0.247
1999 Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. Jama. 281: 634-9. PMID 10029125 DOI: 10.1001/Jama.281.7.634  0.246
2007 Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation. 116: 1497-503. PMID 17846285 DOI: 10.1161/Circulationaha.107.716407  0.246
2012 Glynn RJ, Rosner B. Regression methods when the eye is the unit of analysis. Ophthalmic Epidemiology. 19: 159-65. PMID 22568429 DOI: 10.3109/09286586.2012.674614  0.246
2008 Setoguchi S, Schneeweiss S, Brookhart MA, Glynn RJ, Cook EF. Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiology and Drug Safety. 17: 546-55. PMID 18311848 DOI: 10.1002/Pds.1555  0.246
1988 Hermos JA, Locastro JS, Glynn RJ, Bouchard GR, De Labry LO. Predictors of reduction and cessation of drinking in community-dwelling men: results from the normative aging study. Journal of Studies On Alcohol. 49: 363-8. PMID 3172785 DOI: 10.15288/Jsa.1988.49.363  0.246
1998 Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology. 105: 1213-21. PMID 9663224 DOI: 10.1016/S0161-6420(98)97023-3  0.246
2019 Glynn RJ, Lunt M, Rothman KJ, Poole C, Schneeweiss S, Stürmer T. Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution. Pharmacoepidemiology and Drug Safety. PMID 31385394 DOI: 10.1002/Pds.4846  0.246
2011 Choudhry NK, Avorn J, Glynn RJ, Antman EM, Schneeweiss S, Toscano M, Reisman L, Fernandes J, Spettell C, Lee JL, Levin R, Brennan T, Shrank WH. Full coverage for preventive medications after myocardial infarction. The New England Journal of Medicine. 365: 2088-97. PMID 22080794 DOI: 10.1056/Nejmsa1107913  0.246
2006 Dormuth CR, Glynn RJ, Neumann P, Maclure M, Brookhart AM, Schneeweiss S. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clinical Therapeutics. 28: 964-78; discussion 9. PMID 16860179 DOI: 10.1016/J.Clinthera.2006.06.007  0.245
2018 Libby P, Glynn R, Thuren T, Hilkert R, Ridker P. 358Understanding and mitigating the risk of infection with canakinumab European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy564.358  0.245
1994 Glynn RJ, Rosner B. Comparison of alternative regression models for paired binary data. Statistics in Medicine. 13: 1023-36. PMID 8073198 DOI: 10.1002/Sim.4780131005  0.245
2016 Chandler PD, Akinkuolie AO, Tobias DK, Lawler PR, Li C, Moorthy MV, Wang L, Duprez DA, Jacobs DR, Glynn RJ, Otvos J, Connelly MA, Post WS, Ridker PM, Manson JE, et al. Association of N-Linked Glycoprotein Acetyls and Colorectal Cancer Incidence and Mortality. Plos One. 11: e0165615. PMID 27902713 DOI: 10.1371/Journal.Pone.0165615  0.245
2007 Rosner B, Glynn RJ, Lee ML. A nonparametric test for observational non-normally distributed ophthalmic data with eye-specific exposures and outcomes. Ophthalmic Epidemiology. 14: 243-50. PMID 17896304 DOI: 10.1080/09286580701396704  0.245
2005 Stürmer T, Buring J, Lee IM, Gaziano JM, Glynn RJ. 369: Metabolic Abnormalities and Risk for Colorectal Cancer (CRC) in the Physicians’ Health Study (PHS) American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S93  0.245
2007 Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, Ridker PM. High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Archives of Ophthalmology (Chicago, Ill. : 1960). 125: 300-5. PMID 17353399 DOI: 10.1001/Archopht.125.3.300  0.245
1983 Garvey AJ, Bossé R, Glynn RJ, Rosner B. Smoking cessation in a prospective study of healthy adult males: effects of age, time period, and amount smoked. American Journal of Public Health. 73: 446-50. PMID 6829829 DOI: 10.2105/Ajph.73.4.446  0.245
1988 Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M, Munzenrider J, Verhey L, Urie M, Koehler A. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 95: 992-9. PMID 2845324 DOI: 10.1016/S0161-6420(88)33091-5  0.245
2019 Connolly JG, Schneeweiss S, Glynn RJ, Gagne JJ. Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover Study. Drug Safety. PMID 31321714 DOI: 10.1007/S40264-019-00852-Z  0.244
2018 Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, Schneeweiss S. Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 30165612 DOI: 10.1093/Gerona/Gly197  0.244
2008 Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. Journal of Hypertension. 26: 1780-6. PMID 18698212 DOI: 10.1097/Hjh.0B013E3283077Eef  0.244
2010 Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. Journal of Thrombosis and Haemostasis : Jth. 8: 95-100. PMID 19874474 DOI: 10.1111/J.1538-7836.2009.03677.X  0.244
Hide low-probability matches.